csr in the pharmaceutical industry : the case study of novo nordisk

Upload: david-dhannoo

Post on 11-Feb-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    1/77

    >3>59?6

    4

    Jldptcr 4 Obtraeujtoab

    4"4 Ycscdrjl Idj`mraube

    Ulc pldrgdjcutojdk obeustry os ubko`c gdby atlcr obeustrocs+ euc ta ots bdturc af

    iusobcss tldt erums jdb ic rcgceocs far kofc'tlrcdtcbobm okkbcsscs" Icjdusc af tlos

    jcrtdob bdturc tldt os dttdjlce ta tlos obeustry+ ot os jabsoecrce ta ldvc d kdrmc ctlojdk

    rcspabsoiokoty tawdres tlc puikoj+ far cxdgpkc+ pravoeobm dffaredikc erums ta tlasc

    wla bcce ot"

    Ot sccgs ds of tlc pldrgdjcutojdk obeustry lds d jabsoecrdikc obtcrcst ta war` ab ots

    JZY" ,Bussidug+ 9>>? p "6?/ Ot jdb ic sccb tldt tlc rcdsab jagpdbocs ea tlc romlt

    tlobm drc aftcb pcrjcovce ds strdtcmoj+ ecfcbsovc+ dbe puikoj 'sporotce"

    Ds JZY os bat d abc'wdy rade+ JZY djtoabs jdb ldvc prafaube ,pasotovc/ cffcjts ab

    tlc jagpdby dt tlcor aromob" ,@atkcr dbe Kcc 9>>3+ jotce iy Bussidug 9>>< p"6?/

    Obtcmrdtobm JZY jdb tlcrcfarc iuoke d strabmcr rcputdtoab+ dttrdjt dbe rctdob d

    gatovdtce war`farjc+ iuoke d strabm jagguboty rckdtoabslop+ dbe rceujc rcmukdtary

    avcrsomlt"

    Ulc gast farwdre'kaa`obm farg af JZY os cbmdmobm ds d iusobcss ob sajodk

    rcspabsoikc iusobcss prdjtoscs" Ulcsc vakubtdry jarpardtc iusobcss prdjtoscs ar

    obvcstgcbts ta suppart sajodk jduscs jdb ldvc jabscqucbjcs ab tlc iusobcss

    gaeck otsckf" ,Bussidug+ 9>>?+ p"6?/

    Ulos pdrtojukdr dppradjl ta JZY gomlt ic cspcjodkky dedptce ta deercss tlc

    pldrgdjcutojdk obeustrys gardk ogpartdbjc ta pravoec lckp far tlasc wla drc ob

    bcce"Jagpdbocs wla bcmkcjt tlcor rcspabsoikc iusobcss djtovotocs jdb icjagc db cdsy

    tdrmct iy tlc prcss dbe jabsugcr mraups" Kcofcivrc dbe Gokkcr ,9>>6/ gcbtoab tldt

    pldrgdjcutojdks ldvc d gardk aikomdtoab ta sajocty dbe ta pravoec sajocty wotl

    dffaredikc erums" ,Kcofcivrc dbe Gokkcr+ 9>>6+jotce iy Bussidug+ 9>>?+ p"6

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    2/77

    >3>59?6

    9

    Ulc jarpardtc jrotojdk rcscdrjl mraup Jarpardtc ]dtjl puikoslce d kost af jrogcs

    frag tlc pldrgdjcutojdk scjtar+ tlcsc objkuece8 loml projcs+ didbeabobm tlc paar+

    oggardk gdr`ctobm jdgpdombs+ dbe ldvobm d ba gabcy ba jurc dttotuec" Jarpardtc

    ]dtjl ikdgcs tlc pldrgdjcutojdk obeustry far prdjtojobm ds ot kdicks+ jarpardtcoblugdboty"

    Ulc dutlars Fobcmake ct dk"+ ,9>>3/ rcvcdkce tldt tlc gast kostce ioaiusobcss ctlojdk

    ossucs wcrc fobdbjodk prcssurcs+ projobm+ gdr`ctobm dbe djjcss+ rcscdrjl ctlojs+

    mavcrbdbjc+ dbe mkaidk iusobcss"

    Djjareobm ta tlc Axfare Cbmkosl Eojtoabdry+ tlc tcrg pldrgdjcutojdk ds rckdtobm ta+

    ar cbmdmce ob pldrgdjy+ af tlc bdturc af d gceojobdk erum0 af ar rckdtobm ta tlc

    gdbufdjturc+ usc af ar sdkc af gceojobdk erums" ,Axfare Cbmkosl Eojtoabdry+ 9>49/

    Furtlcrgarc+ Vdb Cmcrddt dbe Idrry ,9>>>6+ p"34/

    Frag kaa`obm dt tlcsc ecfobotoab cxdgpkcs+ ot jdb ic obfcrrce tldt tlc pldrgdjcutojdk

    obeustry objkuecs pldrgdjcutojdk jagpdbocs tldt drc obvakvce ob rcscdrjl dbe

    ecvckapgcbt+ tcst gceojobdk praeujts+ gdr`ctobm+ dbe eostroiutobm erums ta laspotdks

    dbe pldrgdjocs" Ot eacs dppcdr tldt tlc tcrg pldrgdjcutojdk ar pldrgdjcutojdk

    obeustry os vcry irade obecce dbe wokk ecpcbe progdroky ab tlc typc af pldrgdjcutojdk jagpdby dbe wldt tlcy spcjodkosc ob"

    Abc af tlc jldkkcbmcs tldt pldrgdjcutojdks ldvc ta fdjc wlcb jrcdtobm obotodtovcs

    tldt drc kob`ce ta Jarpardtc Zajodk Ycspabsoiokoty ,dbe sustdobdiokoty/ os tlc loml

    cxpcjtdtoabs frag std`clakecrs" Ds Bussidug ,9>>?/ gcbtoabs+ pldrgdjcutojdks

    drc dgabm tlc gast degorce dbe gast jrotojosce af dkk" Ulc obeustrys gdob praeujt

    ds wc `baw os ta pravoec gceojdtoab tldt sdvcs kovcs+ lawcvcr+ atlcr ossucs tldt

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    3/77

    >3>59?6

    :

    surraube tlc obeustry drc sccb ob d bcmdtovc wdy objkuec jasts+ pdtcbt ossucs+ dbe

    dbogdk tcstobm far cxdgpkc"

    Ulcrcfarc ldvobm JZY obotodtovcs ob arecr gust ic tlaumlt ob mrcdt ectdok ds wckk ds

    ogpkcgcbtobm taaks tldt jdb lckp obtcmrdtc dbe sustdob sajodkky rcspabsoikc icldvoaur

    ob d lomlky ctlojdk obeustry"

    Ulc jabjcpt af Jarpardtc Zajodk Ycspabsoiokoty os lcrc ta stdy dbe sajodkky

    rcspabsoiokoty eacs bat fot abc sozc fots dkk dbe jagcs ob gdby eoffc rcbt sldpcs dbe

    fargs" Ulos lds obtcrcstce tlc wrotcr wla wokk eckvc eccpcr obta tlc jabjcpt af JZY

    dbe law ot jdb fot d spcjofoj pldrgdjcutojdk jagpdby iy usobm d jdsc stuey

    dppradjl"

    4"9 Ycscdrjl Aihcjtovcs

    Ulc purpasc af tlc rcscdrjl os ta kaa` dt db obeustry tldt obvakvcs d kat af ctlojdk dbe

    rcspabsoikc ossucs"

    Edbosl eodictcs pldrgdjcutojdk Bava Bareos` wokk ic usce ds d jdsc stuey ta

    okkustrdtc eoffcrcbt gctlaes af obtcmrdtobm jarpardtc sajodk rcspabsoiokoty ob ta tlcor iusobcss gaeck"

    Ulc Edbosl pldrgdjcutojdk os d mkaidk dbe wckk `bawb kcdecr ob obsukob" Frag tlc

    =>s ta tlc 4??>s+ tlc jagpdby wds tdrmctce iy BMAs dbe tlc puikoj wotl rcmdres

    ta praeujt qudkoty+ puikoj lcdktl+ dbe iusobcss ob Zautl Dfrojd" Bava Bareos` ecjoece

    ta td`c ab db ctlojdk dppradjl wotl rcmdres ta ots iusobcss prdjtoscs" Idj` ob 9>>5

    tlc jagpdby fargdkky gdec ots gdbdmcgcbt rcspabsoikc far bat abky djlocvobm

    fobdbjodk tdrmcts iut ta jabjcbtrdtc ab sajodk dbe cbvorabgcbtdk ossucs+ tlcy deaptce

    Halb Ck`obmtabs ,4??5/ t ropkc iattag kobc pdrdeomg ,cjabagoj ,mrawtl/+ cjakamojdk

    ,idkdbjc/+ dbe sajodk ,pramrcss//"

    Bava Bareos` objarpardtce tlc tlrcc gdob pokkdrs af sustdobdiokoty ,cjabagoj+

    cbvorabgcbtdk+ dbe sajodk/ obta tlcor jarpardtc jldrtcr+ wlojl os dkombce wotl gdby af

    ots iusobcss prdjtoscs ta JZY dbe put ob pkdjc gdby jabjrctc djtoabs"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    4/77

    >3>59?6

    5

    Frag deaptobm d garc ctlojdk wdy af tlob`obm+ Bava Bareos` lds sloftce frag icobm d

    lcdvoky jrotojosce jagpdby ta db degorce dbe obbavdtovc jagpdby bat hust ob ots

    bdtovc Ecbgdr` iut ab d mkaidk sjdkc" Ua djtudkky gd`c dkk tlrcc pokkdrs af

    sustdobdiokoty fubjtoab wotl tlc jagpdbys edoky iusobcss prdjtoscs wds povatdk far Bava Bareos` ta icjagc d wckk `bawb JZY kcdecr ob tlc pldrgdjcutojdk obeustry"

    Ulc forst aihcjtovc os ta mdob db obsomlt obta tlc batoab af JZY tlrauml tlc kcbs af

    Bava Bareos`" Ulc pdpcr wokk kaa` dt tlc ecjosoab gd`obm prajcss tlc

    pldrgdjcutojdk jagpdby macs tlrauml wotl rcmdres ta ots rcspabsoikc iusobcss

    prdjtoscs"

    Furtlcrgarc+ tlc scjabe aihcjtovc os ta ecvckap db ubecrstdbeobm af tlc jagpdbys

    strdtcmoj dppradjl dbe law tlcy tdj`kc JZY rckdtce ossucs ob tlc pldrgdjcutojdk

    obeustry"

    4": Ycscdrjl Tucstoabs

    Ot jdb ic vocwce tldt jarpardtc cbmdmcgcbt ob JZY ob tlc twcbty'forst jcbtury os

    jldbmobm dbe ot ots cvoecbt tldt gdby jagpdbocs djrass Curapc drc obtcmrdtobm sagcfarg af JZY ob tlcor edoky iusobcss prdjtoscs" Jagpdbocs taedy ldvc ta ecgabstrdtc

    ta tlcor std`clakecrs ds wckk ds ta d sjcptojdk dueocbjc tldt tlcy drc icobm truc ta

    tlcor ware dbe icobm sajodkky dbe ctlojdkky rcspabsoikc" Ulos lds mat tlc wrotcr

    tlob`obm ab law d jagpdby ko`c Bava Bareos` fdjcs tlcsc jldkkcbmcs af eaobm maae

    ob d lomlky jagpctotovc dbe ctlojdk obeustry" Ulc forst qucstoab tldt tlc wrotcr wokk

    cxdgobc wokk ic law eacs d wckk'`bawb pldrgdjcutojdk jagpdby sustdob d

    rcspabsoikc ogdmc ob d lomlky ctlojdk obeustry1 Zcjabeky ta obvcstomdtc wldt taaksdrc bccece ta cbldbjc d sustdobdikc rcputdtoab dbe gabotar sajodkky rcspabsoikc

    icldvoaur1

    Ob arecr ta ubecrstdbe tlcsc qucstoabs+ tlc tcrg Jarpardtc Zajodk Ycspabsoiokoty wokk

    ic taujlce upab ob mrcdtcr ectdok ob tlc kotcrdturc rcvocw dbe ob jldptcr faur tlc jdsc

    stuey af Bava Bareos` wokk pravoec d mrcdtcr ubecrstdbeobm af wldt icobm rcspabsoikc

    gcdbs ta tlc obsukob pldrgdjcutojdk jagpdby ds wckk ds maobm obta ectdok ab wldt

    taaks dbe prajcsscs drc usce ta gabotar dbe sustdob rcspabsoikc icldvoaur"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    5/77

    >3>59?6

    3

    4"5 Ztrujturc

    Ulc gdob aihcjtovc af tlc obtraeujtoab dbe tlc gctlaeakamy ,jldptcr :/ os ta movc tlcrcdecr db obsomlt obta tlc purpasc af obquory dbe ta pravoec db ubecrstdbeobm af tlc

    rcscdrjl stuey"

    Ds prcvoausky gcbtoabce ob 4":+ tlc bcxt jldptcr wokk jabsost af tlc kotcrdturc rcvocw

    dbe fajus ab tlc jabjcpt af Jarpardtc Zajodk Ycspabsoiokoty iy kaa`obm dt vdroaus

    dutlars ecfobotoabs dbe tlcarocs"

    Ulc obtcbtoab af eaobm tlos os ta ecgabstrdtc tldt JZY os d irade jabjcpt dbe tldt

    cdjl jagpdby tldt deapts d JZY dppradjl slauke ecfobc ots rcspabsoikc iusobcss

    prdjtoscs djjareobm ta spcjofoj strdtcmocs ds wckk ds jagpdby dgiotoabs"

    Furtlcrgarc+ tlc kotcrdturc rcvocw dogs ta slaw tldt obtcmrdtobm JZY os ba abc sozc

    fots dkk strdtcmy"

    Ob jldptcr :+ tlc gctlaeakamy af tlc tlcsos wokk ic eosjussce dbe wokk kaa` dt tlc

    jlascb gctlaeakamojdk prajcsscs tldt ldvc iccb deaptce far tlos rcscdrjl pdpcr"

    Db obtcrprctovost pdrdeomg lds iccb usce ds wckk ds vocwobm tlc warke frag db

    abtakamojdk pcrspcjtovc dkabm wotl atlcr rcscdrjl tcjlboqucs gcbtoabce ob tlc

    jldptcr+ pkus kaa`obm dt wly tlcsc rcscdrjl gctlaes ldvc iccb usce far tlos stuey"

    Ulc faurtl pdrt af tlc tlcsos wokk ic tlc jdsc stuey ab Bava Bareos` wlojl wokk

    objkuec d irocf avcrvocw ab tlc jagpdbys lostary ds wckk cxpkarobm tlcor rcdsabs far

    obtcmrdtobm Jarpardtc Zajodk Ycspabsoiokoty obta tlcor iusobcss strdtcmy" Ulos jldptcr

    wokk dksa objkuec gaecks ab tlc vdroaus taaks tldt drc usce ta sustdob rcspabsoikc

    iusobcss icldvoaur frag usobm Halb Ck`obmtabs Uropkc Iattag Kobc dppradjl ta

    Bava Bareos`s vcry awb taak+ Ulc Bava Bareos` ]dy af Gdbdmcgcbt" Ulc obtcbt oab

    af tlc eosjussoab os ta kaa` dt tlc ecjosoab gd`obm prajcss wlcb ogpkcgcbtobm JZY

    rcmukdtoabs dbe prdjtoscs ds wckk ds kaa`obm dt tlcsc vdroaus taaks dbe sccobm law

    cffojocbt tlcy drc dbe law tlcy gabotar dbe sustdob sajodk rcspabsoikc icldvoaur"

    Ulc tlcsos wokk ic jagpkctce iy dsscssobm tlc rcscdrjl fobeobms dbe tlcb jabjkueobmtlc gdob fobeobms ob tlc jabjkusoab"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    6/77

    >3>59?6

    6

    Jldptcr 9' Kotcrdturc Ycvocw

    9"> Kotcrdturc Ycvocw

    Ecfobobm tlc jabjcpt af JZY os bat ds sogpkc ds ot gdy sccg" Vatdw ,4?=:/ abjcstdtce tldt Jarpardtc Zajodk Ycspabsoiokoty gcdbs sagctlobm+ iut bat dkwdys tlc

    sdgc tlobm ta cvcryiaey" ,Vatdw+ 4?=:+ p"93/ Cvcb taedy pcapkc drc stokk jabfusce

    iy tlc luberces af ecfobotoabs tldt ldvc iccb jrcdtce iy djdecgoj sjlakdrs" Ulc

    jabjcpt af JZY+ sagctogcs+ os gdbopukdtce wotl cdsc ta fot ob wotl abc prc'

    jabjcovce batoab ar atlcr tldt wokk pkcdsc tlc jldorgdb ar tlc jagpdbocs

    sldrclakecrs" ,Lap`obs+ 9>>6+ jotce iy Xu+ 9>>?+ p"4>?+

    p"4s wlojl gdr`s tlc iortl af gaecrb edy JZY"

    Ecfobotoabs mrcw avcr tlc 4?6>s dbe 4?=>s+ far cxdgpkc Frocegdb ,4?=>/+ stdtce

    tldt tlc abky iusobcss af iusobcss os iusobcss + gcdbobm tldt iusobcss lds ba atlcr

    rcspabsoikc purpasc atlcr tldb icobm cjabagojdk"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    7/77

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    8/77

    >3>59?6

    4>+ p"=6/ Jdgpickk ,9>>=/ drmucs tldt gujl af tlc kotcrdturc ab jarpardtc

    sajodk rcspabsoiokoty lds iccb ta sagc cxtcbt+ taa ecsjroptovc dbe slauke progdroky

    fajus ab cxtcrbdk gcjldbosgs tldt obfkucbjc wlctlcr jarpardtoabs icldvc ob d

    sajodkky rcspabsoikc gdbbcr ar bat+ dbe ta of tlcy drc obfkucbjce iy tlc prcssurc af

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    9/77

    >3>59?6

    ?

    strabm dbe wckk rcmukdtce stdtc rcmukdtoabs pkus tlc prcssurc af d systcg af wckk

    armdbosce dbe cffcjtovc obeustrodk sckf'rcmukdtoab" ,Jdgpickk+ 9>>=/

    Zloftobm ta tlc scjabe pcrspcjtovc+ tlc scbscgd`obm dppradjl dksa lds tlc sdgc

    jrotoquc af tlc obstotutoabdk dppradjl wotl rcmdres ta jarpardtc sajodk rcspabsoiokoty+ ot

    lds iccb vocwce tldt JZY lds iccb dppradjlce frag d rdtoabdk pcrspcjtovc dbe taa

    gujl dttcbtoab lds iccb jcbtrce ab tlc batoab af JZY djtovotocs"

    Zcbscgd`obm lds iccb ecsjroice ds d prajcss iy wlojl obeovoeudks ecvckap

    jambotovc gdps af tlcor cbvorabgcbt" ,Yobm & Ydbes+ 4?

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    10/77

    >3>59?6

    4>

    tlc jaggab maae+ dkabm wotl tlcor icldvoaurdk eospasotoab wotl rcspcjt ta tlc

    fukfokgcbt dbe djlocvcgcbt af tlcsc" ,Idsu dbe ^dkdzza+ 9>>>6+

    jotce iy Garsobm dbe Kcbsscb+ 9>>6+ p"953/ Ob deeotoab+ tlc twa dutlars batc tldt iy

    cbmdmobm wotl std`clakecrs rcquorcs eodkamuc frag obtcrbdk dbe cxtcrbdk

    std`clakecrs dbe eodkamuc os votdk far tlc fubjtoab af frcc sajocty dbe jdpotdkosg" Ulos

    kcdes ta ldvobm d iusobcss iuokt ab labcsty dbe apcbbcss iy gdbdmobm std`clakecr rckdtoabslops obtcrbdkky dbe cxtcrbdkky dbe cbmdmobm ob eodkamuc wotl tlcsc vdroaus

    mraups icjagcs db csscbtodk fdjtar wotl rcmdres ta jarpardtc sajodk rcspabsoiokoty"

    Vdkuc jrcdtoab dbe std`clakecr rckdtoabslop gdbdmcgcbt dppcdrs ta ic cvoecbt ob

    Jdrrakks ,9>>:/ dbe Ck`obmtabs ,9>>4/ rcscdrjl" Far cxdgpkc+ Jdrrakk gcbtoabs tldt

    tlc pyrdgoe af JZY rcprcscbts d std`clakecr pcrspcjtovc dbe cdjl faur af tlc

    jagpabcbts ob tlc pyrdgoe af JZY ,cjabagoj rcspabsoiokotocs+ kcmdk rcspabsoiokotocs+

    ctlojdk rcspabsoiokotocs+ dbe plokdbtlrapoj rcspabsoiokotocs/ deercsscs eoffcrcbt

    std`clakecrs" ,Jdrrakk dbe Iujllaktz+ 9>>:+ p"54/

    Garcavcr+ Ck`obmtab dbe wlcckcr ,9>>4/ dksa drmucs wotl d gukto std`clakecr

    dppradjl dbe quatcs tldt ot os icjagobm jkcdr tldt jaggubojdtobm cffcjtovcky wotl

    std`clakecrs ab pramrcss tawdres cjabagoj praspcroty+ cbvorabgcbtdk qudkoty dbe

    sajodk obhustojc o"c" tlc tropkc iattag kobc+ wokk icjagc d ecfobobm jldrdjtcrostoj af

    jarpardtc sajodk rcspabsoiokoty ob tlc 94 st jcbtury" ,Ck`obmtab dbe ]lcckcr+ 9>>4+

    p"4/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    11/77

    >3>59?6

    44

    Ulauml Ck`obmtab dbe wlcckcr dmrcc wotl d std`clakecr dppradjl ta JZY iy usobm

    std`clakecr jaggubojdtoab dbe jabsuktdtoab ds csscbtodk taaks+ ot sccgs tldt lc

    prcfcrs abc'wdy jaggubojdtoab" Zjlakdrs sujl ds Frccgdb lawcvcr+ cgpldsosc

    tlc bcce far d twa'wdy jaggubojdtoab prajcss wotl tlc deeotoab af std`clakecr eodkamuc"

    Habcs ,9>>3/ vocws tldt tlc cxjldbmc ictwccb jagpdbocs dbe tlcor std`clakecr

    mraups os dkwdys twa' wdy" Mrubobm ,4??>/ prapascs d twa ' wdy syggctrojdk gaeck

    tldt obvakvcs eodkamuc ictwccb d jagpdby dbe tlc mcbcrdk puikoj ob arecr ta djlocvc

    d gutudk ubecrstdbeobm+ wlojl gavcs puikoj rckdtoabs dwdy frag icobm pcrjcovce ds

    gdbopukdtovc ta trdbsfargobm dbe td`obm ab iadre guktopkc dttotuecs frag iatl obtcrcst

    af tlc jagpdby dbe std`clakecr mraups" Jlrostcbscb dbe Habcs ,4??6/ gcbtoab tldttwa wdy syggctrojdk jaggubojdt oab prdjtoscs drc garcavcr drmuce ta icjagc

    objrcdsobmky woecsprcde ds std`clakecrs icjagc garc jrotojdk dbe djtovc ob tcrgs af

    JZY" ,Jlrostcbscb dbe Habcs+ 4??6+ p"43>6/ vocw tlrcc typcs af std`clakecr

    rckdtoabs wotl rcmdres ta std`clakecr rckdtoabs dbe kdw jagpdbocs cbmdmc wotl JZY

    jaggubojdtoab" Ulcy gcbtoab tlc tlrcc JZY jaggubojdtoab strdtcmocs ds8 tlc

    std`clakecr obfargdtoab strdtcmy+ tlc std`clakecr rcspabsc strdtcmy dbe+ tlcstd`clakecr obvakvcgcbt strdtcmy" Furtlcrgarc+ tlcy drmuc tldt abc'wdy

    jaggubojdtoab ,fdvaurce iy Ck`obmtab dbe ]lcckcr/ dbe twa'wdy jaggubojdtoab

    fdvaurce iy Frccgdb/ drc iatl ogpartdbt+ lawcvcr+ tlcrc os db objrcdsc ta ecvckap d

    twa'wdy jaggubojdtoab pra jcss wlcb ot jagcs ta ecvckapobm JZY eodkamuc" ]lokc

    abc'wdy obfargdtoab af JZY obotodtovcs os bcjcssdry+ ot os bat cbauml far d

    jarpardtoab ta iuoke dbe gdobtdob kcmotogdjy" ,Garsobm dbe Zjluktz+ 9>>6+ p"45>/

    Ob `d`idesc ct dk"+ ,9>>3/ rcscdrjl ab Jarpardtc sajodk rcspabsoiokoty dbe

    std`clakecr dppradjl8 d jabjcptudk rcvocw + tlcy rcjaggcbe tldt jagpdbocs slauke

    ic pkdjce ab jabstrujtovc dbe apcb eodkamuc wotl tlc dog af jagiobobm slart'tcrg

    pcrfargdbjc wotl kabm tcrg armdbosdtoabdk wcdktl" Db csscbtodk ckcgcbt tldt rckdtcs

    ta std`clakecr gdbdmcgcbt os tlcrcfarc eodkamuc ictwccb tlc jagpdby dbe ots

    std`clakecr mraups ob arecr ta jrcdtc sldrce vdkuc"

    Luggcks ,4??

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    12/77

    >3>59?6

    49

    wlojl kcdes ta eoffcrcbt ,cxpcjtce/ eostroiutoabs af icbcfots dbe iurecbs+ af pkcdsurcs

    dbe pdobs+ af vdkucs+ romlts dbe obtcrcsts dgabmst obtcrprctdtoabs" ,Luggcks+4??

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    13/77

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    14/77

    >3>59?6

    45

    lds iccb lcke ta farg tlc frdgcwar` af JZY prdjtoscs ob Bomcrodb sajocty" Dksa+ tlc

    strabm rckomoaus obfkucbjc ab jagpdby prdjtoscs wotl rcmdres ta JZY lds dksa iccb

    taujlce upab" Cgiceece ob JZY prdjtoscs ob Bomcrod os tlc rckomoaus batoab af moft

    dbe sdjrofojc+ dppdrcbtky+ iraumlt ta kogckomlt iy tlc twa eagobdbt rckomoabs' Oskdgdbe Jlrostodboty" Srop ,9>4>/ quatcs tldt sa far tlc kcss cjabagojdkky ecvckapce

    bdtoabs+ ot os ogpartdbt tldt JZY djtovotocs put sagc fajus ab tlc djtoabs af

    sustdobdikc wcdktl far tlc jagguboty+ pdrtojukdrky far tlc kawcr' objagc sajocty"

    ,Srop+ 9>4>+ p"46/

    Frag obfcrrobm frag Srop ,9>4>/+ tlos jdb ic eabc iy cstdikoslobm tlc ko`cs af

    jagguboty ceujdtoab sjlcgcs+ lcdktl devojc+ maae jarpardtc mavcrbdbjc+ dbe

    qudkoty dssurdbjc" Cffcjtovc ogpkcgcbtdtoab af JZY ob ecvckapobm jaubtrocs tldtldvc wcd` kdw cbfarjcgcbts+ ajjdsoabdk fobdbjodk dbe pakotojdk obstdiokoty+ pavcrty+

    dbe d kaw ceujdtoabdk kcvck+ rcquorcs dksa tlc gdjlobcry af db cffcjtovc ecgajrdtoj

    mavcrbgcbt dbe jovok sajocty" ,Srop 9>4>+p"4?/

    Ob tlc ecvckapobm warke+ ot jdb ic vocwce tldt JZY os bat d taak far sakvobm pavcrty

    dbe d kdj` af war` appartubotocs dbe jarruptoab far cxdgpkc0 lawcvcr+ ot jdb ic

    vocwce ds db csscbtodk obstrugcbt far jagpdbocs ta deapt dbe lckp mavcrbgcbts

    suppart kajdk jaggubotocs dbe kajdk strujturcs"

    9"5"9 Zjdbeobdvod

    Zobjc tlos pdpcr os idsce ab d Zjdbeobdvodb jagpdby+ tlc trdeotoab af sajodk

    rcspabsoiokoty ob Ecbgdr` far obstdbjc+ sajodk rcspabsoiokoty dbe ecgajrdjy ma ldbe

    ob ldbe+ tlc gdhar ecvckapgcbts stdrtce ob tlc kdtcr stdmcs af tlc twcbtoctl jcbturytlcsc tocs drc jabbcjtce wotl tlc cgcrmcbjc af tlc wckfdrc stdtc pkus ldvobm strabm

    sajodk ecgajrdtoj obfkucbjcs"

    Ot jdb vocwce tldt Bareoj iusobcss systcgs drc dt aees wotl tlc iusobcss sajocty

    gaeck af rcspabsoikc iusobcss+ tlos os icjdusc ds Mhkicrm ,9>4>/ puts ot+ tldt JZY

    ogpkojotky mrdbts eosjrctoabdry pawcrs ta iusobcss ob ossucs af mrcdt sajodk dbe

    cbvorabgcbtdk jabjcrb+ wlokc ob d Bareoj jabtcxt sujl ossucs drc jabsoecrce ta

    ickabm tlc puikoj eagdob+ ta ic ecjoece tlrauml ecgajrdtoj+ jakkcjtovc+ ar

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    15/77

    >3>59?6

    43

    rcprcs cbtdtovc prajcsscs" , Mhkicrm+ 9>4>+ p"944/ Zjdbeobdvodb mavcrbgcbts dkk

    ldvc strabm obtcrbdtoabdk prafokcs wlcb ot jagcs ta ossucs ab sustdobdikc

    ecvckapgcbt+ pavcrty+ lugdb romlts+ dbe cbvorabgcbtdk pratcjtoab" Frag kaa`obm dt

    tlcsc prcvoausky gcbtoabce ossucs+ tlcsc ossucs drc tlcrcfarc drc dkk strabmky kob`cewotl tlc jabjcpt af JZY"

    Mhkicrm ,9>4>/ gcbtoabs ob lcr pdpcr Vdroctocs af Jarpardtc Zajodk Ycspabsoiokoty

    ,JZY/8 JZY gccts tlc Bareoj Gaeck tldt tlcrc os d jkcdr kob` wotl scvcrdk ckcgcbts

    af JZY tldt drc pdrtojukdrky objagpdtoikc wotl fubedgcbtdk vdkucs dbe pakotojdk'

    cjabagoj obstotutoabs ob Zjdbeobdvod" Frag obfcrrobm frag Mhkicrm ,9>4>/+ tlos

    sotudtoab wlcrc sagc JZY ossucs drc objagpdtoikc+ Bareoj puikoj pakojocs ab

    Jarpardtc Zajodk Ycspabsoiokoty wokk rcfkcjt tlc aromobdk JZY prdjtoscs!gaeck+lawcvcr+ tlcsc pakojocs wokk ic dktcrce ta fot wotl tlc Bareoj Gaeck" Garcavcr+ ot os

    garc dppdrcbt tldt obtcmrdtobm dbe trdbsfargobm JZY wokk ic sagcwldt sogokdr

    djrass cdjl af tlc Bareoj bdtoabs+ euc ta tlc fdjt tldt tlcrc drc d kat af sogokdrotocs ab

    tlcor vocws ab iusobcss ob sajocty"

    Atlcr tlcarosts drmuc tldt icjdusc Zjdbeobdvodb jaubtrocs gox sajodk wckfdrc wotl

    cjabagoj jagpctovcbcss+ tlcrc os wldt sagc ldvc euiice Bareoj jdpotdkosg" Ot

    sccgs frag d Zjdbeobdvodb paobt af vocw tldt JZY os scjabe icst ds d strdtcmy tldt

    ob atlcr pdrts af tlc warke os sccb ds d progdry ossuc" Ulos os aivoausky euc ta ldvobm

    d vcry strabm wckfdrc systcg ob pkdjc ds wckk ds ldvobm d strabm scbsc af

    mavcrbgcbt pdrtojopdtoab ab ossucs idsce ab jagguboty jabjcrbs"

    Ior`ob ct dk"+ ,9>>?/ rcscdrjl ab D Bcw Iusobcss Gaeck far Zustdobdikc

    Ecvckapgcbt gcbtoab ob tlcor pdpcr tldt Bareoj jaubtrocs lde djquorce sajodkky

    rcspabsoikc dbe sustdobdikc icldvoaurs+ wlojl lds iccb erdwb ta dttcbtoab ta tlccxtcbt ta wlojl tlcor sajocty cxloiotce sldrce sajodk vdkucs" Ob pdrtojukdr+ tlcy batce

    tldt ogpartdbjc wds dttdjlce ta ,4/ sajodk cquoty wotlob d jabscbsus sajocty dbe ,9/

    d kavc af bdturc+ dbe tlc ecmrcc ta wlojl af tlcsc wcrc cgiceece ob tlc jukturc af

    sajocty" ,Ior`ob ct dk"+ 9>>?+ p"9

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    16/77

    >3>59?6

    46

    dbtojopdtcs icbcfots sujl ds icttcr qudkoty cgpkayccs+ garc mcbcrdk jaapcrdtoab+

    cdsocr dvdokdiokoty af kojcbscs dbe garc kodikc jabsugcr suppart" ,Ior`o b ct dk"+ 9>>?+

    p"9s kdubjlce gdby objcbtovc sjlcgcs ta cbjaurdmc jagpdbocs ta cgpkay tlc

    ko`cs af oggomrdbts+ kabm'tcrg ubcgpkayce pcapkc+ dbe tlc ldbeojdppce" Iy tlc bcw

    gokkcbboug+ d erdgdtoj jldbmc ob JZY pakojy taa` pkdjc ds d rcsukt af iattag'up dbe

    d tap eawb prajcss tldt spurrce tlc jaubtrys cbjaubtcr wotl mkaidkosdtoab" Mhkicrm

    ,9>4>/ gcbtoabs tldt tlrauml tlos iattag u p suppky jldob eybdgoj+ d mrdeudk sloft ob

    tlc jabjcptudkosdtoab af JZY taa` pkdjc ob tlc Edbosl eosjaursc frag tlc bdrraw+eagcstoj dmcbed ab objkusovc war`'kofc ossucs tawdres d eosjaursc ob kobc wotl tlc

    obtcrbdtoabdk tropkc iattag'kobc dppradjl ta JZY" ,Mhkicrm+ 9>4>+ p"944/

    Furtlcrgarc+ tlos tap'eawb pakotojdk prajcss wlojl ubjavcrce db cxpkdbdtoab mdp

    wlojl idffkce tlc Edbosl dutlarotocs ab wly Ecbgdr` `cpt ab tappobm

    jagpctovcbcss dbe mrawtl warke rdb`obms" Mavcrbgcbt obtcrvocwccs frag

    Mhkicrms ,9 >4>/ rcscdrjl gcbtoab tldt tlos batoab wds kob`ce ta wldt tlcy jaobce

    tlc Edbosl Gaeck" Lcbjc+ d bcw jabjcptoab af JZY wds iarb+ wlojl rckdtce ta tlc

    eosjaursc af jagpctovcbcss+ cjabagoj mrawtl+ dbe mkaidkosdtoab"

    Ot sccgs tldt Edbosl sajocty pravoecs sagc jukturdk trdots tldt jdb erovc tlc jabjcpt

    af JZY farwdre+ Ldiosjl ct dk"+ ,9>>5/ gcbtoab tldt Edbosl sajocty jdb erovc tlos

    prajcss farwdre iy ldvobm d mcbcrdk jagpctcbjc far eodkamuc dbe bcmatodtoab+ d

    wokkobmbcss ta cbmdmc dbe d irade scbsc af trust drc jukturdk trdots saumlt far ob tlc

    qucst far objrcdsobmky scbsotovoty tawdres d vdrocty af std`c lakecrs" ,Ldiosjl ct dk"+,9>>5/ p":9/

    Ot jdb ic sdoe tldt ot td`cs ecgajrdtoj eosjopkobc dbe jaggubojdtoab s`okks ta jrcdtc d

    rcdsabdikc dbe sdtosfdjtary idkdbjc ictwccb eovcrsc obtcrcsts" Ldiosjl ct dk"+

    ,9>>5 / quatc tldt of Jarpardtc Zajodk Ycspabsoiokoty os diaut objrcdsobm scbsotovoty

    tawdres std`clakecrs+ Edbosl gdbdmcrs sccg ta ldvc d maae paobt af ecpdrturc"

    Ulos jcrtdobty eacs bat gcdb tldt tlcrc drc ba jldkkcbmcs dlcde wotl rcmdres ta

    Edbosl JZY" Ko`c ob gdby atlcr Jaubtrocs+ JZY os d gavobm tdrmct" Far cxdgpkc+

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    17/77

    >3>59?6

    4=

    wldt wds pcrjcovce ds rcspabsoikc icldvoaur fovc ycdrs dma gdy bat ic djjcptce ob

    taedys cvcr jldbmobm iusobcss jkogdtc"

    9"3 Abc sozc eacs bat fot dkk

    Ulraumlaut tlos kotcrdturc rcvocw+ tlc wrotcr lds kaa`ce dt d vdst dgaubt af

    ecfobotoabs frag cdrky jabjcpts ta kaa`obm dt d garc af d scbscgd`obm dppradjl af

    tlc jabjcpt" Ot os jkcdr tldt tlcrc drc gdby uscfuk dbe obsomltfuk ecfobotoabs tldt gdby

    sjlakdrs dbe djdecgojs ldvc javcrce+ lawcvcr+ tlcrc os bat'dbe gast ko`cky jdbbat

    ic d prcjosc ecfobotoab af JZY+ euc ta tlc fdjt tldt tlc ecfobotoab dbe prdjtoscs af tlc

    jabjcpt wokk eoffcr frag abc jaubtry ta dbatlcr+ dbe wokk cvakvc avcr d pcroae af togc+pkus wokk dksa eoffcr dgabm jagpdbocs" Abc dmrcce sogpkofoce ecfobotoab tldt tlc

    wrotcr lds faube os tldt JZY os tlc rcsukt+ ogpkojot ar cxpkojot+ af d forg+ ots rakc ob

    sajocty dbe ots rckdtoabslop wotl ots obtcrbdk dbe cxtcrbdk std` clakecrs" , Drmdbead

    dbe Laovo`+ 9>>?+ p"49/

    Ulos vocw rcfkcjts tlc tds`s af awbcrs dbe gdbdmcrs+ iut dksa std`clakecrs wla

    ldvc d eovoece ogpdjt ab tlc jagpdby" Ulc autjagc wokk vdry frag iusobcss ta

    iusobcss dbe wokk ic kob`ce wotl lostarojdk cvcbts+ m camrdply+ kcmoskdtoab+ sajoctys

    cxpcjtdtoabs+ ds wckk ds jurrcbt trcbes sujl ds mkaidk cjabagoj dbe fobdbjodk

    prcssurcs" Uamctlcr+ tlos fargs tlc frdgcwar` ob wlojl d jagpdby apcrdtcs dbe

    ecfobcs law d jagpdby jdb ecvckap dbe mraw ots JZY djtovotocs"

    Icjdusc tlc iusobcss warke os dkwdys rdpoeky jldbmobm+ ot os tlcrcfarc bat passoikc ta

    dmrcc ab db affojodk ar ubovcrsdk dmrccgcbt ab tlc jabjcpt icjdusc fdjts dbe oecds+

    sajocty+ plokasaply+ dbe tlc cbvorabgcbt drc dkk obtcrjabbcjtce" Ds prcvoauskygcbtoab tlc jabjcpt lds jldbmce avcr togc dbe wokk jabtobuc ta ea sa ob tlc futurc"

    Iy stueyobm dbe rcscdrjlobm gdby oecds dbe ecfobotoabs far tlc purpasc af tlos

    kotcrdturc rcvocw+ wlcb JZY os ecfobce+ tlc jabjcpt gust ic ira`cb eawb dbe

    stueoce iy ogpkojotky ecfobobm tlc wlakc sct af obtcrrckdtce rcspabsoiokotocs dbe rakcs ob

    sajocty" Ob deeotoab+ JZY os bat sogpky d iusobcss ctlojs suihcjt+ iut dksa kob`ce wotl

    pakotojdk ctlojs dbe sajodk ctlojs tldt gust ic dksa td`cb obta jabsoecrdtoab" Ulos os

    icjdusc tlc obtcrpkdy ictwccb iatl stdtc dbe provdtc djtars os jldbmobm dbe

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    18/77

    >3>59?6

    49/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    19/77

    >3>59?6

    4?

    Dktlauml lc batcs tldt tlos ecfobotoab jdb ic pcrjcovce ds icobm sagcwldt vdmuc

    dbe quotc irade+ tlc wrotcr dmrccs wotl tlos ecfobotoab ds std`clakecr obtcrdjtoab os d

    votdk pdrt af tlc JZY dmcbed" Ob deeotoab+ Jdrakk ,4??4/ gcbtoabs tldt JZY

    rcprcscbts sajoctdk cxpcjtdtoabs af jarpardtc icldvoaur0 d icldvoaur tldt os dkkcmceiy d std`clakecr ta ic cxpcjtce iy sajocty ar gardkky rcquorce dbe os tlcrcfarc

    hustofodiky ecgdbece iy sajocty" ,Jdrakk+ 4??4+ jotce iy Zgotl ct dk"+ 9>4>+ p"46:/

    Ot jdb ic jabjkuece tldt frag kaa`obm dt tlos kotcrdturc rcvocw tldt JZY ds d jabjcpt

    os vcry jagpkojdtce dbe irade" Ulc wrotcr strcsscs tldt tlc djjcptdbjc af pravoeobm d

    ubovcrsdk ecfobotoab af JZY os bat passoikc dbe tlcrcfarc jagpdbocs gust ecjoec ab

    law tlcy wdbt ta objarpardtc dbe ecfobc JZY wlojl kob`s eorcjtky ta tlcor obeustry+

    s`okks+ dbe cxpcrtosc" Bat abky wokk jagpdbocs ldvc ta ecjoec wldt JZY gcdbs tatlcg+ tlcy wokk ldvc ta dksa fdjc cvcryedy jldkkcbmcs af icobm sajodkky rcspabsoikc

    dbe ic dikc ta wdk` dbe tdk` JZY cffcjtovcky" Ulos os sagctlobm tldt wokk ic slawb ob

    jldptcr 5 af tlos rcscdrjl pdpcr"

    Jldptcr : Ycscdrjl Ecsomb

    :"4 Ycscdrjl ^lokasaply

    Ulc rcscdrjl plokasaply tldt wokk ic usce wokk ic db obtcrprctovc pdrdeomg icjdusc

    tlc rcscdrjl os rcfkcjtce iy atlcr dutlars dssugptoabs dbe ob deeotoab wokk ic garc

    jldrdjtcrosce iy d garc suihcjtovost stdbjc tawdres tlc bdturc af sjocbjc"

    Ulc abtakamojdk dssugptoab ob tlos pdpcr wokk td`c d bagobdkost vocwpaobt+ wlojl

    obtcrprcts tlc sajodk warke ob db cxtcrbdk jabtcxt tldt os gdec up af jabjcpts+ bdgcs+

    dbe kdicks tldt drc usce ta strujturc rcdkoty dbe gd`c scbsc af tlc cxtcrbdk warke"

    Ulc cxtcrbdk warke os tlcrcfarc bat dssugce ta jabsost af ldre dbe tdbmoikc

    strujturcs dbe cxost obecpcbecbtky af obeovoeudks" ,Iurrckk ct dk"+ 4?=?+ p"5/

    Ulc tcrg abtakamy jagcs frag tlc Mrcc` wares abtas gcdbobm icobm dbe kamas

    gcdbobm tlcary" Icobm os tlc cxtcb ece tcrg wotl tlc jabjcpt af cxostcbjc

    suisugce ubecr ot" ,Jabbdwdy dbe ^awckk+ 9>4>+ p"9?/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    20/77

    >3>59?6

    9>

    D suihcjtovc ubecrstdbeobm lds iccb deaptce far tlos rcscdrjl pdpcr0 tlos os

    icjdusc suihcjtovosg vocws tlc jukturc af db armdbosdtoab ds d rcsuktobm prajcss af d

    jabtobuobm sajodk cbdjtgcbt"

    Furtlcrgarc+ suihcjtovosts wauke drmuc tldt jukturc os sagctlobm tldt os jrcdtce

    tlrauml jagpkcx plcbagcbd tldt objkuecs sajodk obtcrdjtoabs dbe plysojdk fdjtars"

    Zdubecrs ct dk"+ ,9>>?/ gcbtoab tldt ot os tlc gcdbobms tldt drc dttrdjtce ta tlcsc

    plcbagcbd iy sajodk djtars wotlob tlc armdbosdtoab tldt bcce ta ic ubecrstaae ob

    arecr far jukturc ta ic ubecrstaae" ,Zdubecrs+ G" ct dk"+ 9>>?+ p"444/

    Ulc tlore ckcgcbt af tlc rcscdrjl plokasaply far tlos pdpcr os ta dksa td`c d

    jabstrujtovost pcrspcjtovc" Ulos pcrspcjtovc drmucs tldt djtars jabstrujt tlcor awb

    rcdkoty dbe tlcy gd`c scbsc af wldt atlcrs eospkdy ta tlcg" Frag d jabstrujtovost

    pcrspcjtovc+ plcbagcbd ko`c JZY jdb ic ecfobce ds sajodk jabstrujts tldt drc fokkce

    wotl eoffcrcbt gcdbobms ,Olkcb ct dk"+ 9>44+ p"5=:/+ tlcsc gcdbobms drc tlcrcfarc

    obstotutoabdkosce tlrauml vdroaus fargs af prajcsscs tldt drc tlcb obtcrprctce iy

    gdby eovcrsc djtars sujl ds jarpardtoabs+ tlc stdtc+ BMAs+ ctj"

    D kcss rdeojdk vocwpaobt ab rcdkoty lds iccb ogpkcgcbtce ob tlos pdpcr ds ot os

    tlcrcfarc pcrjcovce tldt tlcrc os d warke iatl ob d plysojdk dbe sajodk farg jdb icsccb frag gdby eoffcrcbt paobts af vocw" Ulcsc dssugptoabs tldt drc jrcdtce

    icjdusc ot os drmuce tldt jagpdbocs dbe tlc batoab af Jarpardtc Zajodk

    Ycspabsoiokoty drc sajodk jabstrujtoabs tldt kovc dbe ircdtlc ob tlc sajodk warke iut ea

    bat cxost ob tlc plysojdk warke0 tlcrcfarc tlc sajodk warke wokk ic d gdhar obfkucbjc

    wotl rcmdres ta tlos tlcsos"

    Ulos pdrtojukdr rcscdrjl pdrdeomg wokk tlcrcfarc kcde tlc wrotcr ta eosjuss dbe

    jabjkuec wly Bava Bareos` lcdvoky ogpkcgcbts JZY obta ots strdtcmy+ scjabeky law

    tlc jagpdby gdbdmcs tlc jabjcpt af JZY+ dbe tloreky taujlobm upab futurc

    rcscdrjl dbe rcjaggcbedtoabs"

    :"9 Tudkotdtovc dppradjl

    Tudkotdtovc rcscdrjl os oecdk icjdusc ot eckvcs obta tlc bdturc af pcapkcs vocwpaobts

    dbe pcrspcjtovcs" Cxdgobobm tlc wdy Bava Bareos` obtcmrdtcs ots rcspabsoikc

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    21/77

    >3>59?6

    94

    iusobcss prdjtoscs usobm d jdsc stuey gctlaeakamy movcs tlc wrotcr d eccpcr obsomlt

    ab tlc pldrgdjcutojdk jagpdbys wdy af jldgpoabobm JZY prdjtoscs"

    Ds Idiioc ,9>4>/ gcbtoabs+ tlc qudkotdtovc rcscdrjlcr wokk aftcb dbdkyzc dbe rcpart

    edtd jakkcjtce frag spcjofoj+ oecbtofodikc obeovoeudks" ,Idiioc+ 9>4>+ p"544>+ p"54>3+ jotce iy

    Idugmdrtcb+ 9>49+ p"4:/

    Ycscdrjlcrs sujl ds Garsobm dbe Aswdke ,9>>3/ ,9>>?/ dbe Lapwaae ct dk"+ ,9>4>/

    ,wla ldvc jabeujtce rcscdrjl dbe jdsc stueocs ab Bava Bareos`/ wauke ldvc usce

    tlos dppradjl wlcb edtd jakkcjtobm+ iy ds`obm tlc rcspabecbts of tlcy lde sogokdr vocws rckdtce ta tlcor rcscdrjl ab Bava Bareos`s rcspabsoikc iusobcs s prdjtoscs"

    Coscbldret dbe Mrdcibcr ,9>>=/ strcss tldt tlc diokoty af usobm qudkotdtovc edtd movcs

    db obsomlt obta jagpkcx sajodk prajcsscs+ tlcrcfarc tlos typc af edtd wokk movc tlc

    wrotcr d icttcr ubecrstdbeobm dbe cxpkarc tlc jabjcpt af Jarpardtc Zajodk

    Ycspabsoiokoty dbe law pldrgdjcutojdk jagpdbocs sujl ds Bava Bareos` cgice tlos

    strdtcmy ob tlcor cvcryedy iusobcss prdjtoscs"

    :": Jdsc stuey dppradjl

    Ulc wrotcr obtcbes ab usobm d jdsc stuey dppradjl frag dutlars wla ldvc dkrcdey

    jakkcjtce qudkotdtovc edtd ab tlc jagpdby" Ulc purpasc af usobm d jdsc stuey os far

    obvcstomdtobm armdbozdtoabdk strujturc dbe fubjtoabs ar armdbozdtoabdk pcrfargdbjc"

    Gast rcscdrjlcrs jabsoecr tlc jdsc stuey ta ic rckdtovcky kaw ob obtcrbdk dbe cxtcrbdk

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    22/77

    >3>59?6

    99

    vdkoeoty+ iut ot jcrtdobky lds tlc patcbtodk ta ic d vdkudikc rcscdrjl taak" ,Jabbdwdy

    dbe ^awckk 9>4>+ p"/

    Furtlcrgarc+ usobm d jdsc stuey ds d rcscdrjl taak os ogpartdbt icjdusc ot slaws

    tlc iommcr pojturc" Ot jdb dksa jabbcjt cvcbts wotl tlcor cbvorabgcbt ob db obtcmrdtce

    gdbbcr tldt stdrts wotl tlc rcscdrjl qucstoab dbe cbes wotl fobeobms dbe d

    jabjkusoab",Gdbeo+ 9>>>=/" Djjareobm ta _ob ,4??5/ jdsc

    stuey rcscdrjl os prcfcrdikc ob tlos jabtcxt+ sobjc ot dkkaws tlc obvcstomdtoab ta rctdob

    tlc lakostoj dbe ogpartdbt uboqucbcss af edoky cvcbts ,_ob+ 4??5/"

    Ulc usc af jagiobobm vdroaus jdsc stueocs tamctlcr os icjdusc tlc rcsukts af

    guktopkc jdsc stueocs drc jabsoecrce ta ic garc pcrsudsovc+ dbe avcrdkk tlc

    obvcstomdtoab wokk ic garc raiust ,_ob+ 4??5/"

    Ob atlcr wares+ d gctd'dbdkysos lds iccb deaptce+ wlcb dbdkysts icmob d gctd'

    dbdkysos+ tlcy gust oecbtofy tlc jdscs tldt tlcy wdbt ta stuey ,Ydmob dbe Icj`cr+

    4??9+ jotce iy Yueck+ 9>>>=+ p"=9/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    23/77

    >3>59?6

    9:

    Ob jabtrdst+ tlcrc ldvc iccb jrotojosgs af usobm scjabedry edtd+ far cxdgpkc+ tlc

    djjurdjy af tlc edtd td`cs scvcrdk tlobms obta jabsoecrdtoab" Forstky+ tlcrc os tlc

    qucstoab af wlctlcr tlc scjabedry edtd tldt lds iccb faube jdgc frag d progdry ar

    scjabedry saurjc"

    Ulc bcxt paobt ta kaa` dt os tlc armdbozdtoab tldt aromobdkky taa` pdrt ob tlc edtd

    jakkcjtoab" Ulos kcdes ta tlc qucstoab af wldt os tlc qudkoty af tlcor edtd mdtlcrobm

    ecsomb1 Dbe wldt os tlc `bawb jrceotdiokoty af tlcor edtd jakkcjtoab1 Ulc dmc af tlc

    edtd os dksa votdk+ ]rcb ct dk"+ ,9>>=/ quatc tldt ake obfargdtoab os bat bcjcssdroky

    ide obfargdtoab0 lawcvcr+ ob gdby eybdgoj gdr`cts+ up'ta'edtc obfargdtoab os db

    disakutc bcjcssoty" ,]rcb ct dk"+ ,9>>=/ p"=:/

    Kdstky+ tlc qudkoty af tlc edtd sagctogcs jdb ic ub`bawb+ dmdob+ ]rcb ct dk"+ ,9>>=/

    gcbtoab tldt tlc rcputdtoab dbe jdpdiokoty af tlc jakkcjtobm dmcbjy os ogpartdbt wlcb

    dsscssobm tlc qudkoty af tlc edtd tldt lds iccb pravoece" Ua mdob db obsomlt ab tlc

    avcrdkk qudkoty af tlc edtd+ ot gdy ic wartl `bawobm law tlc edtd wds aromobdkky

    jakkcjtce+ far cxdgpkc+ wldt sdgpkobm pkdb wds usce+ wldt edtd jakkcjtoab wds put ob

    pkdjc+ ctj"

    Ulc wrotcr lds td`cb tlos obta jabsoecrdtoab dbe lds usce tlc gast rcjcbt jdscstueocs ab tlc Edbosl pldrgdjcutojdk jagpdby ob arecr ta mdob d garc af db up' ta'

    edtc obsomlt af tlc jagpdby dbe ots JZY prdjtoscs"

    Ulc fdjt tldt Bava Bareos` os d jagpdby idsce ab rcscdrjl dbe dksa `bawb far

    ldvobm d loml kcvck af trdbspdrcbjy+ ot os fdor ta sdy tldt tlc scjabedry edtd aitdobce

    frag tlc jagpdby os djjurdtc"

    ]otlob tlc jdsc stuey rcscdrjl tlc wrotcr lds trodbmukdtce scjabedry dbe qudkotdtovcedtd frag atlcr jdsc stuey saurjcs" Iy jagiobobm gctlaes ob tlc sdgc stuey d

    rcscdrjlcr jdb pdrtodkky avcrjagc ar jaubtcridkdbjc tlc ecfojocbjocs dbe iodscs tldt

    fkaw frag sobmkc gctlaeakamocs" ,Gokks ct dk"+ 9>4>+ p"=5?/

    Ulc eajugcbtdtoab edtd wokk jabsost af iaa`s dbe rcscdrjl pdpcrs ab Bava Bareos`

    dbe law tlcy ogpkcgcbt JZY+ tlcsc scjabedry edtd rcsaurjcs drc bccece ta

    ecvckap db ubecrstdbeobm af tlc jagpdbys strdtcmy ab JZY dbe law tlc jabjcpt os

    ogpkcgcbtce"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    24/77

    >3>59?6

    95

    :"3 Yckodiokoty dbe VdkoeotyYckodiokoty rcfcrs ta tlc cxtcbt ta wlojl yaur edtd jakkcjtoab tcjlboqucs ar dbdkysos

    prajceurcs wokk yocke jabsostcbt fobeobms" ,Zdubecrs ct dk"+ 9>>?+ p"436/

    ]lokst ab tlc atlcr ldbe+ vdkoeoty rcfcrs ta tlc gctlaes tldt ldvc iccb usce ta mdob

    obfargdtoab dbe wlctlcr tlc edtd os rckodikc dbe jarrcjt" Vdkoeoty ob d butslckk os

    wlctlcr tlc obfargdtoab rcfkcjts tlc trutl dbe wlctlcr ot gcdsurcs wldt os ta ic

    gcdsurce ,Ecbsjagic+ 9>>>+ jotce iy @ar`jlo & Yaugidut 9>>6/

    Ob tlos tlcsos tlc wrotcr lds jdrcfukky poj`ce stueocs tldt ldvc iccb put tamctlcr iy

    jabeujtobm obtcrvocws dbe aiscrvobm Bava Bareos`+ furtlcrgarc+ tlc sckcjtce

    dutlars drc `bawb rcscdrjlcrs ob tlcor fockes af stuey dbe ldvc d mcbuobc obtcrcst ob

    JZY rckdtce stueocs"

    Lawcvcr+ usobm scjabedry edtd lds iccb jrotojosce icjdusc tlc uscr lds ba jabtrak

    avcr tlc edtds vdkoeoty d be rckodiokoty" Xo`gube ct dk"+ ,9>49/ gcbtoab tldt dktlauml

    togcky dbe pcrtobcbt scjabedry edtd gdy fot tlc rcscdrjlcrs rcquorcgcbts+ tlc edtd

    jauke ic obdjjurdtc" Ulc rcscdrjl gctlaes usce ta jakkcjt tlc edtd gdy ldvc

    sagclaw obtraeujce iods ta tlc edtd"

    Ds prcvoausky gcbtoabce+ tlc wrotcr lds troce ta dvaoe ldvobm ba jabtrak avcr tlc

    edtds vdkoeoty dbe rckodiokoty iy jlaasobm sckcjtovc stueocs" Jdsc stueocs dt Bava

    Bareos` wlojl fcdturc ob Fobcmake ct dk"+ ,9>4>/ iaa` IoaObeustry Ctlojs objkuec ob

    ec ptl qudkotdtovc dbdkysos af tlc ^ldrgdjcutojdk jagpdbys prdjtoscs ds wckk ds

    okkustrdtobm jagpdby qucstoabbdorcs tldt drc usce wlcb sckcjtobm rcspabsoikc

    suppkocrs" Lapwaae ct dk"+ ,9>4>/ wla dksa jrcdtce d jdsc stuey dppradjl ab Bava

    Bareos` jkdog ob tlcor iaa` Djjaubtobm far Zustdobdiokoty 8 rdjtojdk Obsomlts tldt tlc

    jdsc stueocs ldvc iccb rcscdrjlce dbe wrottcb iy d kcdeobm tcdg af kcdeobm

    iusobcss dbe gdbdmcgcbt djdecgojs frag S@ dbe jabtobcbtdk Curapcdb

    ubovcrsotocs wla ldvc deaptce tlc cxtcbt ta wlojl dbe law+ sustdobdiokoty

    obfargdtoab lds iccb cgiceece wotl tlc rcmukdr apcrdtoabs af tlc jdsc stuey

    armdbosdtoabs" ,Lapwaae ct dk"+ 9>4> + p":/ Atlcr Dutlars sujl ds Garsobm dbe

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    25/77

    >3>59?6

    93

    Aswdke ,9>>3/ dbe ,9>>?/ wla drc djdecgojs dt tlc Japcbldmcb Iusobcss Zjlaak

    dbe tlc Kabeab Iusobcss Zjlaak rcspcjtovcky ldvc dksa td`cb d sogokdr dppradjl iy

    aiscrvobm dbe jakkcjtobm edtd dt tlc Edbosl jagpdby" Ob deeotoab+ tlcor rcscdrjl wds

    dksa jlcj`ce iy Zusdbbc Ztargcr wla os tlc vojc'prcsoecbt af Bava Bareos`" ^drosodbe Laj`crts ,9>> Bava Bareos`

    Bava Bareos` D!Z wds faubece ob 4?99 iy Dumust @raml+ d Edbosl Baick Kdurcdtc

    ob plysoakamy" @raml wds obsporce iy twa Jdbdeodb rcscdrjlcrs wla lde cxtrdjtce

    obsukob frag d jaws pdbjrcds" @ramls wofc lde typc 9 eodictcs dbe faubece

    Bareos` Obsukobkdiardtaroug ta praeujc obsukob far eodictoj pdtocbts" Ulrcc ycdrs kdtcr+

    twa fargcr jakkcdmucs af Bareos` Obsukobkdiardtaroug+ Ldrdke dbe Ularvdke ^cecrscbjrcdtce d rovdkkce obsukob jagpdby jdkkce Bava Ucrdpcutos` Kdiardtaroug" Iy 4?

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    26/77

    >3>59?6

    96

    Ulc jagpdby spcjodkoscs ob faur tlcrdpcutoj drcds8 eodictcs+ mrawtl largabc

    tlcrdpy+ largabc'rcpkdjcgcbt tlcrdpy+ dbe lcgastdsos gdbdmcgcbt ,ikaae'jkattobm

    dmcbts/"

    Ulc jagpdby os d wckk'`bawb kcdecr ob eodictcs jdrc tlraumlaut tlc warke wotl d

    woec rdbmc af praeujts tldt objkuec obhcjtoab ecvojcs+ bccekcs+ dbe pldrgdjcutojdks"

    Gujl af tlc jagpdbys sujjcss os euc ta pdtcbts ot lakes far obsukob 'eckovcry'

    gctlaes+ ds tlcrc os ba pdtcbt far obsukob otsckf" ,Fobcmake ct dk"+ 9>4>+ p":>9/

    Bava Bareos` bat abky lds d strabm prcscbjc ob ots bdtovc Ecbgdr` iut dksa djrass

    Curapc+ ob 9>>: ot wds oecbtofoce ds tlc comltl kdrmcst pldrgdjcutojdk jagpdby dbe

    jabtobucs ta mraw dbe cbtcr bcw gdr`cts" Far cxdgpkc+ Bava Bareos`-s kdtcst

    obvcstgcbt rcprcscbts tlc mrawobm ob fajus ab Y&E ob tlc cgcrmobm gdr`cts"

    Gdr`cts sujl ds Obeod dbe Jlobd jabtobuc ta cxpcrocbjc db objrcdsc ob eoscdsc

    prcvdkcbjc ds d rcsukt af objrcdsce kofc cxpcjtdbjy dbe kofcstykc jldbmcs tldt ldvc

    ajjurrce tlrauml rdpoe cjabagoj mrawtl" ,BX Eajtar+ 9>49/

    Ulc Zjdbeobdvodb pldrgdjcutojdk jagpdby os d jagpdby idsce ab rcscdrjl" Ob

    9>44 tlcy spcbt E@@ ?"69< gokkoab ab Y&E dbe sdkcs mrcw iy 44# ob kajdk

    jurrcbjocs" ,Bava Bareos` 9>44 Dbbudk Ycpart+ p":/ Kdrs Yciocb Zrcbscb+ tlcprcsoecbt dbe JCA af Bava Bareos` gcbtoabs tldt tlos sdkcs mrawtl+ jagiobce wotl

    jabtobuce fajus ab cffojocbjy af aur apcrdtoabs+ rcsuktce ob apcrdtobm prafot mrawtl af

    444 Dbbudk Ycpart+ p":/

    Ulc sldrc awbcrslop af Bava Bareos` cbsurcs tldt tlc armdbosdtoab lds d loml

    ecmrcc af frcceag+ ds ot bat apcb far td`cavcrs+ far cxdgpkc+ frag kdrmcr

    pldrgdjcutojdk jagpdbocs" ,Garsobm dbe Aswdke+ 9>>3+ p":/ Zldrc jdpotdk af tlc

    jagpdby os eovoece obta D'sldrc dbe I'sldrcs+ tlc I'sldrcs drc kostce ob tlc

    Japcbldmcb+ Kabeab+ dbe Bcw _ar` staj` cxjldbmcs" Ds rcpartce ob tlc 9>44

    dbbudk rcpart+ Bava Bareos` I sldrcs objrcdsce iy 9"3#+ tlc dbbudk rcpart

    gcbtoabs tldt tlos fomurc os ickocvce ta ic kob`ce wotl tlc ecvckapgcbt af tlc

    jagpdbys sldrc projc dbe icobm d kcdecr ob tlc cvcr mrawobm eodictcs jdrc gdr`ct

    ds wckk ds tlrauml cbjaurdmobm pramrcss gdec ob rcscdrjl dbe ecvckapgcbt" Ob

    jabtrdst+ tlc D'sldrcs drc bab'kostce dbe lcke iy Bava D!Z ,wlojl os d provdtc kogotce

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    27/77

    >3>59?6

    9=

    Edbosl jagpdby tldt os 4>># awbce iy tlc Bava Bareos` faubedtoab wlojl wds

    cstdikoslce wotl tlc gcrmcr ob 4?

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    28/77

    >3>59?6

    94>+ p"946/

    Ulc raats tldt kcde ta tlc jagpdbys obtcrcst rcmdreobm sustdobdiokoty jdb ic trdjce

    idj` ta objoecbts tldt stdrtce ob tlc 4?=>s" Ulc jagpdby fdjce dkkcmdtoabs tldt

    ectcrmcbt cbzygcs wcrc dffcjtobm tlc lcdktl af Dgcrojdb cgpkayccs wla wcrc

    obvakvce ob tlc praeujtoab prajcss" Ulc rdgofojdtoabs kcde ta sdkcs ob tlc Dgcrojdb

    gdr`ct ta fdkk0 tlc gdbdmcgcbt dt Bava Bareos` icjdgc fajusce ab tlc vukbcrdiokoty

    af tlc iusobcss euc ta puikoj apoboab"

    Ob arecr ta fox tlos praikcg+ tlc jagpdby saumlt ta rcjambosc tlc irade sct af

    std`clakecrs ta wlag tlc jagpdby awce d rcspabsoiokoty ta+ dbe tlcrcfarc rcfkcjt ab

    tlc ogpdjt tldt lde iccb jdusce"

    Iy 4??>+ dmdob Bava Bareos` wds rcjcovobm garc bcmdtovc gceod dttcbtoab" Ulos

    togc tlc gceod dttcbtoab wds diaut usobm mcbctojdkky gaeofoce armdbosgs+ tlc Edbosl

    jagpdby tlos togc wds rcdey ta obotodtc d garc pradjtovc farg af std`clakecr

    cbmdmcgcbt+ wlojl wds dogce dt oecbtofyobm dbe deercssobm tlc jabjcrbce ossucs

    tldt lde iccb rdosce"

    Lapwaae+ D" ct dk"+ ,9>4>/ paobt aut tldt tlc jagpdby sujjcssfukky pcrsudece tlasc

    obvakvce ob gd`obm tlc dkkcmdtoabs ta rcvosc dbe jarrcjt tlcg dbe+ ob sa eaobm+ ta kogot

    tlc cxtcbt af bcmdtovc gceod javcrdmc" ,Lapwaae+ ct dk"+ 9>4>+ p"94=/

    Ulc cbmdmcgcbt kce ta cgpkayobm abc af tlc dutlars wla wds obvakvce wotl tlc

    dkkcmdtoabs ab iadre+ Halb Ck`obmtab wla aromobdkky jaobce tlc tcr g tlc tropkc iattag

    kobc ob 4??5" Ck`obmtab taa` d rcvocw af tlc jagpdbys iusobcss prdjtoscs+ dberckdtce tlcg ta tlc cbvorabgcbt" D ycdr kdtcr+ Bava Bareos` sct up ots forst

    sustdobdiokoty strdtcmy+ wlojl fajusce ab tlc cbvorabgcbtdk jabjcrbs dt tlc togc"

    Cvcr sobjc tlcy jrcdtce tlcor forst sustdobdiokoty strdtcmy idj` ob tlc ?>s+

    std`clakecr cbmdmcgcbt dbe trcbe dbdkysos ldvc icjagc edoky dbe csscbtodk taaks

    wlojl lckp tlc jagpdby ta oecbtofy bcw jabjcrbs tldt drc ar passoiky jauke ic

    icjagc bcw gdtcrodk"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    29/77

    >3>59?6

    9?

    Abc af tlcsc jagpdby taaks os tlc kcdrbobm jurvc+ wlojl dkombs tlc prajcsscs af

    ecfobobm gdtcrodkoty wotl tlc obtcmrdtoab af tlc jagpdbys iusobcss prdjtoscs" Ossucs

    af ogpartdbjc far sustdobdiokoty ob Bava Bareos` ldvc jldbmce frag d prceagobdbtky

    cbvorabgcbtdk fajus ta d fajus tldt objkuecs lcdktl+ sdfcty dbe ioactlojs ossucs+ dbed fajus ab law ta obtcmrdtc ossucs af sajodk rcspabsoiokoty" ,Garsobm dbe Aswdke+

    9>>3+ p"3/

    Fomurc 4 slaws tlc kcdrbobm jurvc tldt Bava Bareos` uscs ta rcfkcjt law ossucs

    rckdtce ta sustdobdiokoty drc icobm obtcmrdtce obta tlc iusobcss" Ztd`clakecr

    cbmdmcgcbt os csscbtodk wlcb oecbtofyobm tlc rckcvdbt ossucs dbe lckps sldpc tlc

    wdy tlc gdbdmcgcbt ecdks wotl tlcg" Far cvcry ossuc+ obeojdtars drc oecbtofoce ob

    arecr ta trdj` dbe gabotar pcrfargdbjc+ abjc tlc rcspabsc lds iccb ecfobce"

    Diavc8 Fomurc 48 Ulc Bava Bareos` Kcdrbobm Jurvc

    ,Jotce ob Garsobm dbe Aswdke+ 9>>3+ p"6/

    Cffcjtovcky gdbdmobm std`clakecr rckdtoabs icjdgc d strdtcmoj taak far Bava Bareos`

    icttcr ta ubecrstdbe tlcor pcrspcjtovcs+ dbe ta ic dikc ta dedpt ta jldbmobm sajoctdk

    cxpcjtdtoabs" ,Icbbctt+ ct dk"+ 9>44+ p"9?=/ Avcr tlc ycdrs tlos lds mdobce tlc

    jagpdby d vcry vdkudikc trust jdpotdk"

    Lawcvcr+ ob 9>>4+ tlc Edbosl pldrgdjcutojdk faube otsckf icobm pcrjcovce ob d

    bcmdtovc wdy iy tlc gceod" Ulc sotudtoab tlos togc wds ta ea wotl d Zautl Dfrojdb

    jaurt jdsc avcr pdtcbt romlts0 farty atlcr pldrgdjcutojdk jagpdbocs dksa taa` pdrt"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    30/77

    >3>59?6

    :>

    Bava Bareos`s rcputdtoab far kostcbobm ta std`clakecr jabjcrbs wds j ldkkcbmce" Ulc

    jagpdby wla lde pdrtojopdtce ob tlc jdsc ta ecfcbe tlc romlts af tlc pdtcbt erums+

    wlojl jdb ic sdoe ta ic tlc jarc iclobe tlc pldrgdjcutojdk iusobcss gaeck+ tlc

    puikojs vocwpaobt wds tldt Bava Bareos` wds prcvcbtobm paar pcapkc fragdjjcssobm kofc sdvobm erums"

    Ulc jaurt jdsc icjdgc d turbobm paobt ab law tlc jagpdby djts wotlob sajocty"

    Ulos os abc sotudtoab wlcrc tlcor kcdrbobm jurvc wauke ic uscfuk dbe Bava Bareos`

    eoe rcspabe ta tlc idj`kdsl tldt tlcy fdjce ob Ecbgdr` wotl rcmdres ta tlc Zautl

    Dfrojdb pdtcbt romlt jdsc" Ulcy rcspabece iy obvcstobm ob d bugicr af obotodtovcs tldt

    wds jrcdtce ta lckp ogpravc djjcss ta lcdktljdrc ob tlc ecvckapobm warke"

    Mrubom & Lubt ,4?44+ p"9?=/

    Ulc rdgofojdtoabs af tlos jldbmc frag ldvobm aromobdkky d gobesct af gdbdmobm

    std`clakecrs cxpcjtdtoabs ta rcspcjtobm tlcor rakcs garc ds wckk tlc jabjcrbs tlcy

    gdy ldvc ab icldkf af tlc pcapkc dbe jaggubotocs tlcy scrvc+ ds wckk ds tlccbvorabgcbt" Ulos gobe sct os bat ta ic td`cb ob sujl d pdssovc wdy+ iut dksa iy

    td`cb djtoab+ dbe ubecrstdbeobm tlc rakc af ctlojs dbe ta fastcr saube ecjosoab

    gd`obm"

    Dt prcscbt+ icjdusc af tlcsc bcmdtovc jabbatdtoabs sujl ds tlc Zautl Dfrojdb jaurt

    jdsc idj` ob 9>>4+ Bava Bareos` pravoecs obsukob rckdtce praeujts dt d vcry kaw jast

    ta tlc ecvckapobm warke" Zujl objoecbjcs frag tlc pdst lds obfkucbjce tlc abmaobm

    ecvckapgcbt af abc tlcor `cy taaks+ tlc tropkc iattag kobc+ dbe tlc jagpdby baw

    objkuecs d sct tdrmct far tlc dgaubt af sdkcs dbe gdr`ctobm rcprcscbtdtovcs wlag

    wokk ic trdobce ob tapojs sujl ds iusobcss ctlojs"

    5"9 Ulc Uropkc Iattag Kobc Dppradjl

    Ulc batoab af Uropkc Iattag Kobc ,:IK/ djjaubtobm lds icjagc objrcdsobmky

    fdsloabdikc ob gdbdmcgcbt+ jabsuktobm+ obvcstobm+ dbe BMA jorjkcs avcr tlc kdst fcw

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    31/77

    >3>59?6

    :4

    ycdrs" ,Bargdb dbe GdjEabdke+ 9>>5+ p"95:/ Ulc gdob oecd iclobe tlc tropkc

    iattag kobc dppradjl os tldt d jagpdbys sujjcss slauke ic gcdsurce bat abky iy

    tlc fobdbjodk iattag kobc+ iut dksa tlrauml sajodk dbe cbvorabgcbtdk pcrfargdbjcs"

    Frag stueyobm tlc kotcrdturc rcvocw frag Jldptcr 9+ d jaggab tlcgc tldt eoe dppcdr

    wds tlc batoab af std`clakecr ogpartdbjc wotl rcmdres ta JZY" Ds Bargdb dbe

    GdjEabdke ,9>>5/ paobt aut+ ot os dksa d truosg tldt forgs jdbbat ic sujjcssfuk ob tlc

    kabm rub of tlcy jabsostcbtky eosrcmdre tlc obtcrcsts af `cy std`clakecrs " ,Bargdb

    dbe GdjEabdke+ 9>>5+ p"95:/ Ulc dppdrcbt bavckty af usobm tlc tropkc iattag kobc

    stcgs frag ots suppartcr mraups sujl ds jaggubotocs+ jabsugcrs+ cgpkayccs+

    suppkocrs+ ctj"+ slauke ic qudbtofoce+ jdkjukdtce+ dueotce+ dbe tlcb rcpartce ob d

    jagpdbys dbbudk rcpart"

    Abc af tlc garc cbeurobm jkoj ls af gaecrb gdbdmcgcbt os tldt of yau jdbt

    gcdsurc ot+ yau jdbt gdbdmc ot" ,Bargdb dbe GdjEabdke+ 9>>5+ p"95:/ Ulos os abc

    taak ob pdrtojukdr tldt os uscfuk far jaggubojdtobm wotl vdroaus std`clakecr mraups iy

    puikoslobm sajodk+ cbvorabgcbtdk+ dbe cjabagoj pcrfargdbjcs ab db dbbudk idsos"

    Garcavcr+ Z`aukaueos ct dk"+ ,9>>?/ gcbtoab tldt gdby jagpdbocs draube tlc warke

    ldvc rcdkosce tldt jabvcbtoabdk fobdbjodk rcparts dbe rckdtce djjaubtobm gctlaesdkabc drc bat suffojocbt ta pravoec obfargdtoab ob obtdbmoikc dsscts dbe bab'fobdbjodk

    ossucs af tlc armdbosdtoab " ,Z`aukaueos ct dk"+ 9>>?+ p"9?s+ wlcb gdbdmcgcbt tlob` '

    tdb` DjjaubtDiokoty icmdb ta usc tlc ware ob ots war`" Halb Ck`obmtab ,ds prcvoausky

    gcbtoabce ob 5"4/ wds iclobe tlc jabjcpt+ tlc tcrg faube puikoj jurrcbjy wotl tlc

    4??= puikojdtoab af tlc Irotosl ceotoab af Halb Ck`obmtabs Jdbboidks wotl Far`s8 Ulc

    Uropkc Iattag Kobc af 94 st Jcbtury Iusobcss" ,Bargdb dbe GdjEabdke+ 9>>5+ p"955/

    Ulc Edbosl ^ldrgdjcutojdk uscs tlc tropkc iattag kobc dppradjl wlojl kob`s d sct af

    `cy tdrmcts ta sustdobdikc dbe sajodk rcspabsoikc madks" Fomurc 9 okkustrdtcs spcjofoj

    obeojdtars tldt drc usce ds wckk ds obeojdtobm tlc rcdsabs far usobm tlcg ,ogpdjt/"

    Ulcrc drc sox strdtcmoj drcds tldt drc kob`ce wotl Bava Bareos` s tropkc iattag kobc

    pcrfargdbjc+ tlcy objkuec8

    4" Kovobm aur vdkucs0

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    32/77

    >3>59?6

    :9

    9" Djjcss ta lcdktl0

    :" Aur cgpkayccs0

    5" Aur usc af dbogdks0

    3" Cja'cffojocbjy dbe jagpkodbjc0 dbe6" Cjabagoj jabtroiutoab

    Diavc8 Fomurc 98 Obeojdtars af tlc tropkc iattag kobc pcrfargdbjc ,Jotce ob Garsobm

    dbe Aswdke+ 9>>?+ p"?:

    Ulos gdob taak tldt os usce dt tlc jagpdby rcdssurcs tldt Bava Bareos` td`cs

    djtoabs tldt drc jabsostcbt wotl rcspabsoikc dbe sustdobdikc icldvoaur" Garsobm dbe

    Aswdke ,9>>?/ gcbtoab ob tlcor rcscdrjl tldt dkk gctrojs usce ob tlc tropkc iattag

    kobc dmmrcmdtc pcrfargdbjc djrass dkk iusobcss ubots ta prcscbt tlc fukk pojturc"

    ,Garsobm dbe Aswdke+ 9>>?+ p"?9/

    Iy usobm tlc tropkc iattag kobc+ trdbspdrcbt rcpartobm os tlcrcfarc d votdk obstrugcbt far djjaubtobm pcrfargdbjc dbe kaa`obm dt sajodk+ cbvorabgcbtdk+ dbe cjabagoj

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    33/77

    >3>59?6

    ::

    dspcjts" Zusdbbc Ztargcr+ tlc gdbdmcr af jarpardtc std`clakecr rckdtoabs quatcs

    tldt tlos os wlcrc wc jdb djjaubt far aur dppradjl ta eaobm iusobcss ob d sobmkc

    eajugcbt dbe jalcsovcky prcscbt pcrfargdbjc+ pramrcss+ pasotoabs+ dbe strdtcmoj

    obotodtovcs ds wckk ds tlc eokcggds dbe `cy ossucs wc fdjc ds d pldrgdjcutojdkjagpdby" Gast ogpartdbtky+ wldt wc prcscbt ob tlc rcpart os tlc rcsukt af aur

    obtcrdjtoabs dbe cbmdmcgcbts wotl std`clakecrs" ,Garsobm dbe Aswdke+ 9>>?+ p"?9/

    5"9"4 Ulc ED]B ,Eodictcs+ Dttotuecs+ ]oslcs+ dbe Bcces/ ^ramrdggc

    Db cxdgpkc af Bava Bareos` usobm ots tropkc iattag kobc dppradjl dbe obvakvobm

    std`clakecr rckdtoabs jdb ic sccb frag tlc ED]B pramrdggc" Ulc pramrdggc

    stdrtce ob 9>>4 wds dogce dt cxpkarobm dttotuecs dbe bcces af iatl eodictcs

    suffcrcrs dbe lcdktljdrc prafcssoabdks ta kob` jrotojdk mdps ob tlc avcrdkk jurc affcrobm"

    Zrcb Z`avkube+ scboar devosar af Jarpardtc Lcdktl ^drtbcrslops+ sccs tlc `cy

    ckcgcbt ds tlc usc af tlc ED]B stuey ds d vclojkc ta mct dkk tlc eoffcrcbt pcapkc

    raube tlc sdgc tdikcirobm pdtocbts+ lcdktl prafcssoabdks+ pdycrs+ tlc gceod

    tamctlcr ta fobe bcw wdys ta war` garc cffcjtovcky tamctlcr ab tlc sdgc tds`"

    ,Icssdbt dbe Uoeck+ 9>44+ p"6:/

    Ulc qucstoab tldt rcgdobs os wly eoe Bava Bareos` mct obvakvce1 Abc gdhar rcdsabos tldt tlc rukcs af tlc mdgc draube jlraboj eoscdsc gdbdmcgcbt drc ob fdjt sloftobm"

    Icssdbt dbe Uoeck ,9>44/ stdtc far cxdgpkc+ ]LA ,]arke Lcdktl Armdbosdtoab/

    cstogdtcs tldt eodictcs os d iommcr `okkcr tldb DOEZ wotl draube :"9 gokkoab ecdtls

    dttroiutdikc ta tlc eoscdsc' dbe ots jagpkojdtoabs'cvcry ycdr" ,Icssdbt dbe Uoeck+

    9>44+ p"6:/

    Ob deeotoab+ wldt os garc dkdrgobm os tldt ob tlc ecvckapobm warke+ wlcrc abc ob tcb

    ecdtls af deukts dmce :3 ta 65 drc euc ta eodictcs ,Icssdbt dbe Uoeck+ 9>44+ p"6:/+

    tlcrcfarc jlraboj eoscdscs sujl ds eodictcs drc d gdhar ossuc dbe ot os sagctlobm

    tldt lcdktljdrc systcgs drc objrcdsobmky fajusobm ab dbe tryobm ta gobogosc tlc

    sajoa'cjabagoj iurecb af eoscdsc iy rcarmdbosobm tlc jurc prajcss dbe strujturc"

    Ulcsc gdhar slofts pasc tlc ros` tldt tlc praeujt'fajusce pldrgdjcutojdk obeustry os

    fdkkobm iclobe" ,Icssdbt dbe Uoeck+ 9>44+ p"65/

    Ulc tropkc iattag kobc os ogpkcgcbtce frag td`obm pdrt ob tlc ED]B pramrdggc

    ubecr tlc idbbcr af tlc Bdtoabdk Eodictcs ^ramrdggcs ,BE^s/" Ulcsc

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    34/77

    >3>59?6

    :5

    pramrdggcs+ rdtlcr tldb fajusobm ab tlc praeujt soec af tlobms+ fajus ab suppartobm

    ceujdtoab af lcdktl jdrc prafcssoabdks dbe iuokeobm jkobojs far eodictcs ob tlc

    ecvckapobm warke far cxdgpkc"

    Ulc jagpdby JCA+ Kdrs Yciocb Zrcbscb drmucs iy affcrobm dbe devajdtobm tlc

    romlt sakutoabs far eodictcs jdrc wokk wc ic sccb ds d rcspabsoikc jagpdby" Of wc hust

    sdy erums+ erums+ erums+ tlcy wokk sdy movc us d ircd`$ Ulos os jkcdrky maae

    prdjtojc'iut tlc patcbtodk kcdvobm diaut bcw dppradjlcs ta jdrc+ cspcjodkky ubecr

    rcsaurjc' jabstrdobce jabeotoabs+ dksa rcprcscbts ogpartdbt loeecb Y&E obvcstgcbt"

    ,Icssdbt dbe Uoeck+ 9>44+ p"65/ Ulc progdry ubecrkyobm probjopkc os ta ecvckap dbe

    tcst mcbcroj pratatypc pkdbs wlojl jdb ic tcstce ob vdroaus jaubtrocs" Abc cxdgpkc

    os frag Udbzdbod"

    Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt ta rcdjl aut icyabe tlcor jurrcbt justagcrs+

    Bava Bareos`s Jarpardtc Zajodk Ycspabsoiokoty ,JZY/ pramrdgs ldvc iccb faube ab

    ecvckapobm obfrdstrujturc dbe `bawkcemc ob tlc warkes paarcst jaubtrocs t a lckp trcdt

    pcapkc suffcrobm frag eodictcs" ,Fobcmake ct dk"+ 9>>3+ p":4=/

    Frag kaa`obm idj` dt tlc kotcrdturc rcvocw+ cspcjodkky frag 9"5"4 D vocw af JZY ob tlc

    ecvckapobm warke + ot wds gcbtoabce tldt pdrtojukdrky ob Dfrojd+ JZY os jabeujtce obgarc af d plokdbtlrapoj dppradjl" Far cxdgpkc+ Srop ,9>4>/ gcbtoabce ob tlc jldptcr

    tldt cstdikoslobm tlc ko`cs af jagguboty ceujdtoab sjlcgcs dbe lcdktl devojc ds

    wckk ds lckpobm kajdk jaggubotocs dbe kajdk strujturcs os d jaggab JZY prdjtojc ob

    tlc ecvckapobm warke"

    Bava Bareos`s JZY cffarts ob Udbzdbod wcrc db cdrky pokat" Ulc obsukob

    pldrgdjcutojdk icmdb war`obm wotl kajdk eodictcs dssajodtoabs ds wckk ds scttobm up

    jkobojs dbe laspotdks+ trdobce stdff dbe pravoeobm rckcvdbt gceojdk cquopgcbt"

    Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt tlcy ldvc kcdrbce tldt ot eacsbt lckp ta hust movc

    d kat af obsukob ta d jaubtry0 yau ldvc ta trdob tlc eajtars dbe burscs dbe iuoke

    obfrdstrujturc" ,Fobcmake ct dk"+ 9>>3+ p":4

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    35/77

    >3>59?6

    :3

    tlcy jdb ic ecdkt wotl kajdkky" ,Icssdbt dbe Uoeck+ 9>>4+ p"63/ Ulos pokat dppradjl

    wlojl stdrtce ob tlc cdrky 9>>>s dbe tlc gavc os baw tawdres fobeobm ubeodmbasce

    suffcrcrs dbe ecvckapobm dppradjlcs ta gdbdmc tlcor eodictcs ob d wdy tldt tlcy ea

    bat cxpcrocbjc jagpkojdtoabs wlojl os wlcrc tlc gdhar jasts drosc frag" Ulos batabky lds ogpkojdtoabs far cxpkarobm d patcbtodk gdr`ct far obsukob iut dksa gavobm

    Bava Bareos` obta d iradecr drcd af lcdktljdrc gdbdmcgcbt" Furtlcrgarc+ tlc

    kcdrbobm prajcss far tlc jagpdby os diaut eoffcrcbt bdtoabdk lcdktljdrc systcgs dbe

    law ta war` wotlob tlcg dbe irobm jldbmc ,sujl ds ob Udbzdbod/"

    5"9"9 Zldrce Vdkuc dbe tlc Uropkc Iattag Kobc

    Zusdbbc Ztargcr+ wla os tlc vojc prcsoecbt dt tlc jagpdby+ gcbtoabs ob d JZY

    Curapc mcbcrdk dsscgiky cvcbt tldt tropkc iattag kobc gdbdmcgcbt os diaut vdkuc

    jrcdtoab ob twa wdys+ ots diaut gobogosobm tlc eawbsoecs ,Fomurc :/ + ots diaut

    gdbdmobm ros`s+ csscbtodkky ot os diaut maae lausc`ccpobm+ tldt yau drc sogpky

    cxpcjtce ta ea ob gdobtdobobm tlc kojcbsc ta apcrdtc+ tlc atlcr pdrt os diaut erovobm

    obbavdtoab dbe law yau jdb erovc rcvcbucs dbe law yau jdb erovc obtdbmoikc vdkucs

    sujl ds rcputdtoab+ cgpkaycc cbmdmcgcbt+ ctj" ,Ztargcr+ 9>44/

    Ulc jagpdbys tropkc iattag kobc dppradjl jdumlt tlc dttcbtoab af warke 'rcbawbce

    iusobcss tlcarost+ Gojldk ^artcr frag tlc Ldrvdre Iusobcss Zjlaak" Ob 9>44+ Bava

    Bareos` rckcdsce d puikojdtoab jdkkce Ulc Ikucprobt far jldbmc8 jldbmobm eodictcs ob

    Jlobd tlc puikojdtoab os idsce ab law ta strcbmtlcb tlc lcdktljdrc systcg ds wckk

    ds cstdikoslobm kajdk std`clakecr rckdtoabs wlojl drc `cy ckcgcbts af Bava Bareos`s

    kabm tcrg iusobcss strdtcmy"

    Maobm idj` ta Zusdbbc Ztargcrs JZY Curapc spccjl+ tlc vojc prcsoecbt gcbtoabs

    tldt tlc dppradjl wc ldvc td`cb os ta try dbe dsscss law jdb wc tlcb jrcdtc dbe

    jdpturc dbe jaggubojdtc wldt wc jdkk cbldbjce vdkuc+ tlc sldrce vdkuc obeojdtcs

    tldt tlcrc os d poc af d jcrtdob sozc dbe wldt wc drc drmuobm os tldt wc jdb djtudkky

    gd`c tlc poc iommcr" ,Ztargcr+ 9>44/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    36/77

    >3>59?6

    :6

    Diavc8 Fomurc :8 Zldrce vdkuc usobm tlc tropkc iattag kobc ,Jotce ob Bava Bareos`

    ,9>44/ p"49/

    Frag obfcrrobm frag Ztargcr ,9>44/ abc wdy tldt tlc jagpdby lds gdec tlc poc

    iommcros iy tdrmctobm tlc ecvckapobm warke dbe usobm d plokdbtlrapoj dppradjl wotl

    rcmdres ta tlcor JZY cffarts"

    Garcavcr+ iy tdrmctobm drcds wlcrc jlraboj eoscdsc os pdrtojukdr loml+ tlc batoab af

    sldrce vdkuc jdb ic usce ta lckp jagidt tlcsc eoscdscs dbe okkbcsscs ds wckk ds

    jrcdtc db appartuboty far futurc obeustry mrawtl"

    Djjareobm ta ^artcr+ jrcdtobm sldrce vdkuc os d pdbdjcd far dkk mkaidk lcdktl

    jldkkcbmcs" Zagc cffarts wokk obcvotdiky eosdppaobt+ dbe gdr`ct fdokurcs wokk rcgdob"

    Bcvcrtlckcss+ pldrgdjcutojdk dbe gceojdk ecvojc jagpdbocs ldvc db cxtrdareobdry

    appartuboty ta lckp rceujc mkaidk suffcrobm dbe okk'lcdktl iy iuokeobm d jagpctotovc

    devdbtdmc ob tlc kaw dbe goeekc objagc jaubtrocs tldt wokk ubecrpob futurc obeustrymrawtl" ,^artcr+ 9>44+ p"39/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    37/77

    >3>59?6

    :=

    Ssobm tlos sldrce vdkuc strdtcmy ds wckk tlc tropkc iattag kobc ob ecvckapobm

    jaubtrocs+ d qucstoab tldt jagcs ta gobe os law tlc gabcy os pugpce obta obvcstobm

    obta ecvckapobm gdr`cts"

    Ulc JCA af Bava Bareos` Kdrs Yciocb Zrcbscb gcbtoabs ob Fobcmake ct dk"+ ,9>>3/

    rcscdrjl tldt lc ecfcbes tlc jagpdbys JZY obotodtovcs ta los std`clakecrs ds O lde

    ta ds` aur sldrclakecrs far tlc gokkoabs far tlc Eodictcs Faubedtoab" O jdbt

    mudrdbtcc d rcturb far tlcg iut wldt O eoe tckk tlcg os tldt tlc cbcrmy tlos typc af

    obvcstgcbt puts obta tlc forg wokk objrcdsc aur obtcrbdk praeujtovoty0 ot objrcdscs aur

    dttrdjtovcbcss ds d jagpdby ta war` far iy cgpkayccs" Ulcb tlc atlcr dspcjt+ tldt

    ob tlc std`clakecrs cycs os abky spcjukdtoab+ os tldt tlc ecvckapgcbt af ecvc kapobm

    jaubtrocs wokk icbcfot tlc warke ob tlc kabm' rub" ,Zrcbscb+ 9>>3+ jotce iy Fobcmake ctdk"+ 9>>3+ p":9>/ Objrcdsobm iatl sldrclakecr dbe std`clakecr trust+ Zrcbscb lds

    slawb tlcg tldt tlc jagpdbys JZY obotodtovcs ea objrcdsc tlc dttrdjtoab af bc w

    cgpkayccs dbe objrcdsc cgpkaycc sdtosfdjtoab"

    Uaedy+ wotl tlc tropkc iattag kobc ds d iusobcss probjopkc+ Bava Bareos` td`cs d

    lakostoj vocw+ scc`obm ta idkdbjc jabjcrbs far dkk std`clakecr mraups wotl

    jabsoecrdtoabs af bat abky sajodk ossucs ob tlc ecvckapobm warke+ iut dksa

    cbvorabgcbtdk ossucs dbe sustdobobm kabm'tcrg rcvcbucs"

    Bavas sldrclakecr obtcrdjtoab dbe mkaidk ossucs jdb ic sccb ob Fomurc 5" @obma

    ,9>>6/ gcbtoabs diaut Fomurc 5 tldt pdrtojukdr fajus os movcb ta tlc pcapkc wlasc

    lcdktljdrc bcces Bava Bareos` scrvcs" Ulraumlaut tlc vdkuc jldob std`clakecrs drc

    obvakvce ob ecvckapobm garc sustdobdikc sakutoabs8 tlc armdbosdtoab war`s wotl

    BMAs dbe tlc puikoj scjtar ob pdrtbcrslops+ kcdrbobm wotl std`clakecrs" ,@obma+

    9>>6+ p"9?/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    38/77

    >3>59?6

    :/

    Iy cstdikoslobm d kob` ictwccb lcdktl ds d gdob erovcr af wcdktl+ ot jdb ic vocwce

    tldt ot lds iccb passoikc ta pursuc tropkc iattag kobc strdtcmocs ob d wdy tldt

    objrcdsobmky tdrmcts tlc jarc af iusobcss prajcsscs'ar gd`obm tlc poc iommcr ds

    Ztargcr ,9>44/ prcvoausky gcbtoabs' ob gdr`cts dbe mavcrbdbjc gcjldbosgs" Ulos

    dppradjl os tlcrcfarc sldpce tlrauml cxtcbsovc std`clakecr cbmdmcgcbt pkus

    cgiceeobm armdbosdtoabdk icldvoaur dbe rcspabsoikc iusobcss apcrdtoabs"

    5": Ulc Idkdbjce Zjarcjdre

    Ulc idkdbjce sjarcjdre os db obtcrbdk gdbdmcgcbt systcg dbe jabtdobs autjagc

    gcdsurcs ob faur pcrspcjtovcs+ bdgcky fobdbjodk+ justagcr+ obtcrbdk prajcss+ ds wckk

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    39/77

    >3>59?6

    :?

    ds kcdrbobm dbe mrawtl ta movc cgpldsos ta saft fdjtars sujl ds `bawkcemc iuokeobm+

    obtcrbdk prajcss cffojocbjy dbe justagcr arocbtdtoab" ,Jlcbm+ 9>4>+ p"3/ ]ciicr dbe

    Zjlffcr ,9>>>/+ @dpkdb dbe Bartab ,4??=/+ dbe Oioe ,9>>4/ gcbtoab tlc faur

    pcrspcjtovcs ds8

    Ulc fobdbjodk pcrspcjtovc obeojdtcs+ of tlc trdbsfargdtoab af d strdtcmy

    kcdes ta ogpravce cjabagoj sujjcss" Ulus+ tlc fobdbjodk gcdsurcs

    dssugc d eauikc rakc8 ab tlc abc ldbe+ tlcy ecfobc tlc fobdbjodk

    pcrfargdbjc d strdtcmy os cxpcjtce ta djlocvc" Ab tlc atlcr ldbe+ tlcy

    drc tlc cbepaobt af jdusc dbe cffcjt rckdtoabslops rcfcrrobm ta tlc atlcr

    IZJ pcrspcjtovcs"

    Ulc justagcr pcrspcjtovc ecfobcs tlc justagcr!gdr`ct scmgcbts+ ob

    wlojl tlc iusobcss jagpctcs" Iy gcdbs af dppraprodtc strdtcmoj

    aihcjtovcs+ gcdsurc+ tdrmcts dbe obotodtovcs tlc justagcr vdkuc

    prapasotoab os rcqucstce ob tlc justagcr pcrspcjtovc+ tlrauml wlojl tlc

    forg!iusobcss ubot wdbts ta djlocvc d jagpctotovc devdbtdmc ob tlc

    cbvosdmce gdr`ct scmgcbts"

    Ulc obtcrbdk prajcss pcrspcjtovc oecbtofocs tlasc obtcrbdk iusobcss

    prajcsscs+ wlojl cbdikc tlc forg ta gcct tlc tdrmct gdr`cts dbe tlasc

    af tlc sldrclakecrs"

    Fobdkky+tlc kcdrbobm dbe mrawtl pcrspcjtovc ecsjroics tlc

    obfrdstrujturc wlojl os bcjcssdry far tlc djlocvcgcbt af aihcjtovcs af

    tlc atlcr tlrcc pcrspcjtovcs" Ob tlos jdsc+ tlc gast ogpartdbt drcds drc

    qudkofojdtoab+ gatovdtoab+ dbe madk arocbtdtoab af cgpkayccs+ dbe

    obfargdtoab systcgs"

    ,Fommc ct dk+ 9>>9+ p:/

    Ulc idkdbjce sjarcjdre eostobmuoslcs otsckf frag atlcr gdbdmcgcbt taaks wotl

    ots sckcjtoab af bab'fobdbjodk dbe fobdbjodk gcdsurcs+ wlojl os rckdtce iy d

    jdusc'dbe'cffcjt rckdtoabslop" Ulos gdbdmcgcbt taak jaggubojdtcs d lakostoj

    gaeck tldt rckdtcs ta obeovoeudk cffarts dbe djjagpkoslgcbts wotl iusobcss

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    40/77

    >3>59?6

    5>

    ubot aihcjtovcs" Zcjabeky+ tlc idkdbjce sjarcjdre os db csscbtodk fcceidj`

    systcg far jagpdbocs ko`c Bava Bareos` ta usc+ tlc devdbtdmc af tlc

    idkdbjce sjarcjdre os tldt ot cbjaurdmcs cgpkayccs ta jabsoecr tlc ogpdjt af

    tlcor ecjosoabs ab prafotdiokoty ,Zgotl dbe @og+ 9>>3+ p"=>/Furtlcrgarc+ tlcy dksa gcbtoab tldt atlcr devdbtdmcs drc bat hust kajdkosce

    dbe fajusce ob tlc slart tcrg" Ds cdjl ecpdrtgcbt rcdjlcs ots madk,s/+ ot dksa

    lckps tlc cbtorc jagpdby icjagc jkascr ob dttdobobm ots tdrmcts" Ulc idkdbjce

    sjarcjdre gctlae tlcrcfarc ogpravcs dkombgcbt dgabm eovosoabdk ar obeovoeudk

    madks ds wckk ds tlc jagpdbys madks dbe strdtcmocs"

    Kob`obm tlc idkdbjce sjarcjdre wotl lcdktljdrc+ Doecgdr` ,9>>4/ stdtcs tldt

    gdbdmcrs ob lcdktljdrc drc obsporce dt scgobdrs+ jabfcrcbjcs+ dbe jaurscs

    iy jabsuktdbts ta gaecrbosc tlcor gdbdmcgcbt djjaubtobm systcg usobm tlc

    bcw gordjukaus trcdtgcbt af tlc idkdbjce sjarcjdres" ,Doecgdr`+ K"M"+

    9>>4+ p"9:/

    ^rafcssoabdks ob tlc gceojdk obeustry scc tlc passoiokoty af usobm tlc idkdbjce

    sjarcjdre ta put tlc ko`cs af pdtocbts+ prajcss+ dbe cgpkayccs ta tlc farc"

    Lcdktljdrc armdbosdtoabs ldvc tlc frcceag ta ecsomb d idkdbjce sjarcjdre ob

    dby wdy tldt gccts tlc armdbosdtoabs bcces+ iut d idkdbjce sjarcjdre far d

    lcdktl jdrc scjtar gust dttcgpt ta djjugukdtc tlc bcces af gdby

    armdbosdtoabs tlus+ lcdktljdrc armdbosdtoabs jdb jlaasc obeojdtars tldt rcfkcjt

    tlcor awb spcjofoj gossoab+ scrvojcs+ dbe pramrdgs+ dbe apcrdtobm

    cbvorabgcbt" ,Xckgdb ct dk"+ 9>>:+ p"4>/

    Garsobm dbe Aswdke ,9>>3/ ecsjroic tlc idkdbjce sjarcjdre dt Bava

    Bareos` ds Ulc Idkdbjce sjarcjdre os tlc gdbdmcgcbt taak far cgiceeobm

    dbe jdsjdeobm tlc tropkc iattag kobc dppradjl tlraumlaut tlc armdbosdtoab"

    Ulc sjarcjdre os d votdk ckcgcbt af tlc jarpardtc mavcrbdbjc sct'up ob Bava

    Bareos` dbe tlus d vcry pawcrfuk taak ta cbsurc obtcmrdtoab af tlc

    sustdobdiokoty dppradjl obta dkk iusobcss prajcsscs" ,Garsobm dbe Aswdke+

    9>>3+ p"4>/

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    41/77

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    42/77

    >3>59?6

    59

    Diavc8 Fomurc 38 Db cxdgpkc af law tlc idkdbjce sjarcjdre jdsjdecs ,Jotceob Garsobm dbe Aswdke+ 9>>3+ p"4:/

    Ulc diavc cxdgpkc slaws law tlc idkdbjc sjarcjdre troj`kcs eawb frag tlc

    jarpardtc soec romlt eawb ta tlc eodictcs foboslce praeujts" Ssobm tlc

    eodictcs foboslce praeujts tcdg ds db cxdgpkc+ fargdk gabotarobm td`cs pkdjc

    ab d gabtlky idsos+ edtd ab dkk @^O s ,@cy ^crfargdbjc Obeojdtars/ drc tlcb

    jdkjukdtce dbe upedtce ab tlc jagpdbys O"U" systcg" Cdjl sotc gdbdmcr dt

    Bava Bareos` lds ta prcpdrc d gabtlky rcpart tldt cxpkdobs dby ecvodtoabs

    frag tlc sct tdrmcts" Furtlcrgarc+ dby kdrmc ecvodtoab tldt tlc systcg paobtsaut lds ta ic dbswcrce wotl d spcjofoj djtoab pkdb" Obfargdk gcctobms dksa

    td`c pkdjc0 tlc purpasc af tlcsc gcctobms os ta rcfkcjt ab pcrfargdbjcs dbe ta

    scc of tlcor tdrmcts tlcy ldvc fargukdtce ldvc mabc djjareobm ta pkdb+ dbe of

    bat wly"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    43/77

    >3>59?6

    5:

    Db csscbtodk pdrt af tlc sjarcjdre os tldt ot os db ogpartdbt fcceidj` taak+ @dpkdb dbe

    Bartab ,9>>=/ quatc tldt d strdtcmoj fcceidj` systcg slauke ic dikc ta tcst+

    vdkoedtc+ dbe gaeofy tlc lypatlcsos cgiceece ob d iusobcss ubots strdtcmy" ,@dpkdb

    dbe Bartab+ 9>>=+ p"4>6/ Iy cstdikoslobm iatl slart tcrg dbe kabm tcrg madks+ wotlobtlc pkdbbobm prajcss+ cxcjutovcs drc tlcrcfarc dikc ta farcjdst rckdtoabslops ictwccb

    jldbmcs ob pcrfargdbjc erovcrs dbe tlc dssajodtce jldbmcs ob tlc sct madks"

    5"5 Fdjokotdtoab

    Fdjokotdtoab os jabeujtce iy d sgdkk tcdg af vcry cxpcrocbjce stdff gcgicrs+ usudkky

    tlos sgdkk tcdg os jlascb iy scboar gdbdmcrs wotlob tlc jagpdby" Uds`s objkuecdsscssobm iusobcss ubot pcrfargdbjcs ob jagpkodbjc wotl tlc fubedgcbtdks dbe

    vdkucs af Bava Bareos`s jldrtcr+ tlcy oecbtofy dbe sldrc icst prdjtoscs djrass tlc

    jagpdby iy jakkcjtobm cvoecbjc frag tlc soxty ar sa fdjokotdtars tldt drc td`cb pcr

    dbbug dbe praeujc d rcpart tldt os suigottce ta tlc cxcjutovc gdbdmcgcbt tcdg"

    Lapwaae+ D" ct dk"+,9>4>/ quatc tldt tlc gctlaeakamy af tlc fdjokotdtars ob dkk tlc

    diavc tds`s os gujl kcss qudbtotdtovc ob dppradjl tldb UIK rcpartobm ar idkdbjce

    sja rcjdres" ,Lapwaae+ ct dk"+ 9>4>+ p"99

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    44/77

    >3>59?6

    55

    tlc jagp dby lds ecvosce" ,Lakecb+ B" + 9>>9 p"4:>/ Ob deeotoab+ tlc jagpdby jdb

    jcrtdobky ic mrdtcfuk tawdres tlc fdjokotdtars far raatobm aut gdkprdjtojcs tldt dffcjtce

    Bava Bareos` warkewoec"

    Far cxdgpkc+ ob d jcrtdob jaubtry+ twa fdjokotdtars wcrc dikc ta ubcdrtl d gdkprdjtojc

    tldt wds bat abky d ircdjl tawdres tlc jagpdbys jaec af jabeujt+ iut dksa d

    pubosldikc affcbjc ob tldt jaubtry" Ulc pdrtojukdr jaec af jabeujt wds wckk `bawb ta

    Bava Bareos`+ dbe far tlc forst togc tlc jagpdby wds dikc ta oecbtofy law tlos

    gdkprdjtojc wds icobm jaggottce" Abjc dkk af tlos obfargdtoab lde iccb scbt ta tlc

    jagpdbys Japcbldmcb lcdequdrtcrs iy tlc fdjokotdtars+ d gcctobm wotl dkk tlc

    scboar gdbdmcrs tldt wcrc rcspabsoikc far rcmoabdk iusobcsscs wcrc oggceodtcky

    jdkkce"

    Ulc rcsukt kce ta Bava Bareos` td`obm jarpardtc djtoab ta stdgp aut tlos sjdg" Ot jdb

    ic sdoe tldt fdjokotdtoab os d prafaube kcdrbobm cxpcrocbjc0 abc fdjokotdtar stdtce tldt

    tlc kcdrbobm cxpcrocbjc wds ko`c d rcdk kofc GID+ icjdusc icobm d fdjokotdtar

    cxpascs yau ta cvcry ogdmobdikc iusobcss sotudtoab" ,Lakecb dbe Mkosiy+ 9>4>+

    p"4?5/

    Ulcsc gdby taaks tldt Bava Bareos` uscs ecfobotcky movcs d kcdrbobm cxpcrocbjc+wlctlcr ots iy usobm tlc idkdbjce sjarcjdre ar iy usobm fdjokotdtars+ ob deeotoab

    fakkawobm tlc Bava Bareos` ]dy af Gdbdmcgcbt ,wlojl wokk ic eosjussce ob 5"3/ dbe

    gd`obm surc gcgicrs af stdff ubecrstdbe ot os csscbtodk wotl rcmdres ta law tlc

    jagpdby jabeujts ots iusobcss prdjtoscs"

    5"3 Bava Bareos` ]dy af Gdbdmcgcbt Ulc Bava Bareos` ]dy af Gdbdmcgcbt lds iccb usce sobjc tlc kdtc 4??>s dbe os d

    frdgcwar` tldt os ecsombce ta bdvomdtc tlc wdy ob wlojl cvcry jagpdby cgpkaycc

    dbe gdbdmcr war`s draube tlc warke" Ulos frdgcwar` jabsosts af tlrcc pdrts+ Ulc

    Vosoab+ Ulc Jldrtcr+ dbe ^akojocs"

    Ulc forst pdrt tlc vosoab+ cxpkdobs wldt tlc jagpdby wdbts ta djlocvc dbe tlc avcrdkk

    madks tldt rckdtc ta pdtocbts+ sajocty+ dbe tlcor gcgicrs af stdff" Ulc vosoab stdtcs

    tldt wc wokk ic tlc warkes kcdeobm eodictcs jagpdby" ]c wokk affcr praeujts dbe

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    45/77

    >3>59?6

    53

    scrvojcs ob atlcr drcds wlcrc wc jdb gd`c d eoffcrcbjc" ]c wokk djlocvc jagpctotovc

    iusobcss rcsukts" D hai lcrc os bcvcr hust d hai" Aur vdkucs drc cxprcssce ob dkk aur

    djtoabs" Aur lostary tckks us+ ot jdb ic eabc" ,Zalg+ 9>>=+ p"49/

    Ulc scjabe scmgcbt+ Ulc Jldrtcr+ objkuecs d ecjkdrdtoab af Bava Bareos`s vdkucs

    tldt drc djjaubtdikc+ rcspabsoikc+ dgiotoaus+ cbmdmc wotl ots std`clakecrs+ ds wckk

    icobm apcb dbe labcst+ pkus ta ic apcb ta jldbmc" Ob deeotoab+ tlc jldrtcr dksa

    objkuecs tlc pldrgdjcutojdk jagpdbys jaggotgcbts ta icobm fobdbjodkky

    rcspabsoikc+ cbvorabgcbtdkky rcspabsoikc+ dbe sajodkky rcspabsoikc ,tlc tlrcc pdrts af

    tlc tropkc iattag kobc/"

    Ulc fubedgcbtdks os d kost tldt cdjl ubot dbe tcdg gust dioec iy" Ulc jldrtcr muoecs

    dkk jagpdbocs tldt drc dssajodtce wotl tlc Bava Mraup+ dbe tlc cgpkayccs jaggot

    ta war`obm wotlob tlos muoece frdgcwar`" Ulc tlore jrotcrod+ pakojocs+ okkustrdtc maae'

    prdjtojc dbe ctlojdk muoedbjc rcmdreobm spcjofoj apcrdtoabdk ossucs wotlob tlc

    fakkawobm drcds8 tlc cbvorabgcbt+ jaggubojdtoab+ fobdbjc+ lcdktl dbe sdfcty+ O"U"+

    pcapkc+ kcmdk+ qudkoty+ purjldsobm+ ros` gdbdmcgcbt+ mkaidk lcdktl+ dbe ioactlojs"

    Cdjl movcb pakojy cxpkdobs wldt ot wokk ea dbe law ot wokk ic eabc" Kaa`obm dt tlcioactlojs pakojy far cxdgpkc+ Bava Bareos` dogs ta jabtobuausky ogpravc ioactlojdk

    pcrfargdbjc" Ulos gcdbs tlc jagpdby wokk8

    ^ragatc ioactlojdk dwdrcbcss tlraumlaut tlc jagpdby

    Cstdikosl dbe cbsurc loml ctlojdk stdbedres far8

    4/ Cxpcrogcbts ab kovobm dbogdks9/ Jkobojdk trodks dbe usc af lugdb gdtcrodk:/ Mcbc tcjlbakamy

    Zct loml ctlojdk stdbedres far aur cxtcrbdk pdrtbcrs+ jabtrdjt rcscdrjlarmdbozdtoabs dbe suppkocrs dbe gabotar tlcor pcrfargdbjc

    Cbmdmc ob std`clakecr eodkamuc dbe pdrtbcrslops dbe rcpart ab aur

    pcrfargdbjc

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    46/77

    >3>59?6

    56

    Kovc up ta tlc sporot+ vdkucs+ probjopkcs+ dbe jabtcbt af rckcvdbt jabvcbtoabs+kdws dbe rcquorcgcbts

    ,Fobcmake ct dk"+ 9>>3+ p":>>3+ p"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    47/77

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    48/77

    >3>59?6

    549+ p":=:/ Ua dvaoe eosjrogobdtobm prdjtoscs wlcb lorobm bcw jdbeoedtcs+

    gdbdmcrs dt Bava Bareos` Gcxoja sckcjt tlcor patcbtodk cgpkayccs idsce ab tlcor

    hai prafokc"

    Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt eurobm tlc rcjruotgcbt prajcss+ Bava Bareos`

    pdys pdrtojukdr dttcbtoab ta wlctlcr tlc jdbeoedtc wokk fot wotl tlc jagpdbys jukturc

    dbe bat hust ic dikc ta pcrfarg wckk tcjlbojdkky" ,Fobcmake ct dk"+ 9>>3+ p":4>/ Ulc

    rcjruotgcbt dbe sckcjtoab gdbdmcr dt Bava Bareos` Gcxoja cxpkdobs tldt wc ldvc

    djjcss ta tlc gdob LY apcrdtoabdk prajcsscs af tlc forg0 lawcvcr wc bccece ta

    dedpt ot ta tlc Gcxojdb kcmoskdtoab" Lawcvcr+ Bava Bareos`s plokasaply os

    jagpkctcky eoffcrcbt frag Ptldt afW atlcr jagpdbocs tldt O ldvc war`ce far ,SZD dbe

    Gcxoja/" Baw+ O ldvc ta gd`c surc tldt tlcrc os ba eosjrogobdtoab ob dby af aur LY

    suisystcgs" ,Ldytab ct dk"+ 9>49+ pp" :=:+:=5/

    Ulc plokasaply cbjagpdsscs tlc armdbosdtoabdk vdkucs dbe jukturc tldt Bava

    Bareos` trocs ta jrcdtc draube tlc warke dbe gd`c surc cgpkayccs dkomb tlc BavaBareos` ]dy af Gdbdmcgcbt ob tlcor cvcryedy war`obm cbvorabgcbt" Ulc LY

    gdbdmcr dt Bava Bareos` Gcxoja jaggcbts djrass Bava Bareos`+ wc drc war`obm

    ldre ta ogpkcgcbt d kcdrbobm jukturc ta lckp pcapkc iuoke bcw jagpctcbjocs quoj`ky"

    ,Ldytab ct dk"+ 9>49+ p":=3/ Ot jdb ic obfcrrce tldt tlc Edbosl pldrgdjcutojdk

    jagpdbys jldkkcbmc ob Gcxoja os ta gd`c surc tldt tlc cgpkayccs ubecrstdbe dbe

    ickocvc tlc jagpdbys vdkucs dbe ta cbjaurdmc tlcg ta deapt tlcsc vdkucs frag

    usobm tlc Bava Bareos` ]dy af Gdbdmcgcbt"

    Ulc JCA Kdrs Yciocb Zrcbscb cxpkdobs law tlos os pcrjcovce eurobm db obtcrvocw

    wotl tlc Curapcdb Iusobcss Farug+ wc ldvc d eostobjt jukturc icjdusc wc drc

    dkombce jkascky wotl aur aromob" ]c ldvc d sajodk rcspabsoiokoty0 wc ldvc rcspcjt far

    tlc obeovoeudk" Ots batlobm Edbosl atlcr tldb wc ldvc db obirce ubecrstdbeobm tldt

    jagpdbocs jdbbat apcrdtc ob d vdjuug+ dbe wc ecpcbe ab sajocty dbe wc bcce ta

    gd`c d jabtroiutoab ta ic dikc ta cxost kabm' tcrg" ,Zjlokkcr+ 9>>=+ p"3

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    49/77

    >3>59?6

    5?

    5"6 Jdusdk Gdps

    Frag kaa`obm idj` dt tlc kotcrdturc rcvocw+ ot jdb ic sdoe tldt Bava Bareos` td`cs d

    scbscgd`obm dppradjl wotl rcmdres ta ots JZY cffarts" Ds prcvoausky gcbtoabce ob

    tlc kotcrdturc rcvocw+ djjareobm ta Idsu dbe ^dkdzza ,9>>

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    50/77

    >3>59?6

    3>

    ^dmc 5?8 Fomurc =8 Ztd`clakecr Gdbdmcgcbt dt Bava Bareos` ,jotce ob ^droso dbeLaj`crts+ 9>>

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    51/77

    >3>59?6

    34

    af gdp rcprcscbts d jagpkctc rcprcscbtdtoab af d sajodk systcg+ dbe tlcrcfarc

    dkkaws dkk vocwpaobts ta ic rcprcscbtce" Ob jabtrdst+ Bdrdydbdb dbe Drgstrabm

    ,9>>3/ eosdmrcc dbe sdy tldt tlc dmmrcmdtc dppradjl eacs bat cgpldsozc tlc

    jdusdk kaaps ob tlc jakkcjtovc gdp" Far tlos rcdsab+ ot gdy bat pravoec d fukkrcprcscbtdtoab af sajodk systcgs+ icjdusc typojdkky sajodk systcgs jabsost af gdby

    djtars wotl sombofojdbtky eovcrsc vocwpaobts" ,Bdrdydbdb dbe Drgstrabm+ 9>>3+

    p"453/Ulc scjabe typc af gdppobm+ jabmrcmdtc gdppobm+ tlos dppradjl jcbtrcs ab

    tlc oecbtofojdtoab af `cy jdusdk kaaps tldt erovc systcg eybdgojs" ,Iaumab+ 4??9+

    jotce iy Udtojjlo+ 9>4>+ p"44?/ Ulc oecd iclobe tlos pdrtojukdr typc af gdppobm

    systcg os tldt strcsscs jdusc'dbe'cffcjt rckdtoabslops" Udtojjlo ,9>4>/ paobts aut tldt

    tlcsc gdps drc sogpkcr tldb tlc sug af obeovoeudk gdps+ sa tldt dkk passoikc

    jabfkojtobm vocws af tlc sajodk systcg drc bat fukky rcprcscbtce" ,Udtojjlo+ 9>4>+

    p"44?/ Furtlcrgarc+ Bdrdydbdb dbe Drgstrabm ,9>>3/ strcss tldt tlcsc jdusdk kaaps

    drc votdk ds tlcy obeojdtc d sajodk systcgs oecbtoty dbe jldbmc ds wckk ds tlc

    systcgs jagpkcx icldvoaurs" Kdstky+ tlc war`slap gdppobm prajcss fajuscs ab d

    jabscbsudk frdgcwar` wlojl os put tamctlcr dt d mraup kcvck" ]ar`slaps+ ar mraup

    gcctobms+ drc wlcrc tlc gaeck os iuokt iy dkk pdrtojopdbts+ doece iy tlc fdjokotdtar ,tlc

    rcscdrjlcr/ wlasc rakc os jcbtrdk far tlc sujjcss af tlc scssoab" ,Udtojjlo+ 9>4>+

    p"44?/ Ulos typc af dppradjl os gdobky suotdikc far sgdkkcr mraups dbe bat

    rcjaggcbece far kdrmc mraups ar armdbosdtoabs ds ot prcscbts d kogot af suihcjtovoty+

    lawcvcr tlos dppradjl jdb ic usce dkabc ar jagiobce wotl atlcr gctlaes ta

    ogpravc d sldrce cffart af jakkcjtovc gdppobm" Atlcr rcscdrjlcrs ,Dj`crgdbb ct dk"+

    4??=0 Eoffcbidjl+ 4?

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    52/77

    >3>59?6

    39

    ta iuokeobm std`clakecr trust dbe dogce dt rceujobm iusobcss ros`s+ objrcdsobm

    apcrdtoabdk cffojocbjy+ pursuobm praeujt eoffcrcbtodtoab ds wckk ds jrcdtobm d bcw

    gdr`ct spdjc"

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    53/77

    >3>59?6

    3:

    Diavc8 Fomurc >

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    54/77

    >3>59?6

    35

    5"6"4 Yceujobm Iusobcss Yos`

    Gdby sjlakdrs ldvc ubecrkobce tlc fdjt tldt d pradjtovc stdbjc ab jarpardtc sajodk

    rcspabsoiokoty os aftcb tlc rcsukt af d jagpdby strdtcmy dogce dt rceujobm tlc kcvck af

    jarpardtc ros`" ,Edvoe+ 4?=:0 Eykkoj`+ 4???0 Ycobldret+ 9>>>0 _dzoho+ 9>>50 jotce iy^droso dbe Laj`crts+ 9>>>49/

    Garcavcr+ Bava Bareos` MGA cxpcrt @bue Vde stdtcs tldt wc icldvc ob apcbbcss

    wlcb wc ecdk wotl ossucs wlojl jdusc puikoj jabjcrb wc scc ot ds aur aikomdtoab ta

    jaggubojdtc ab dby ossuc wotl d pcrjcovce ros` ta sajocty" ,Bava Bareos`+ 9>49/

    Abc gdob erovcr far Bava Bareos`s cbmdmcgcbt ob JZY rckdtce djtovotocs avcr tlc

    ycdrs sccgs ta ldvc iccb idsce draube gceod dttcbtoab0 pdrtojukdrky tlc ros` af BMAs jdgpdombobm dmdobst tlc pldrgdjcutojdk modbt"

    Jdgpdomb ros` rcfcrs ta tlc passoiokoty af icobm dttdj`ce iy BMAs ds icobm

    rcprcscbtdtovc af d wlakc scjtar" ,Laj`crts+ 9>>6/ _dzoho ,9>>5/ gcbtoabs ob los

    rcscdrjl pdpcr Uawdre d tlcary af sajodk ros` tldt tlos prceagobdbtky ajjurs of d forg

    os tlc gdr`ct kcdecr cvcb of ot os bat tlc warst affcbecr ob tlc obeustry" Kob`obm tlos

    wotl Bava Bareos`+ tlc jagpdbys obtcrcst wotl rcmdres ta mkaidk lugdb romlts far

    cxdgpkc+ icobm tlc gdr`ct kcdecr ob obsukob+ tlc jagpdby fdjcs tlc ros` af icobm

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    55/77

    >3>59?6

    33

    sobmkce aut iy mavcrbgcbtdk dbe bab'mavcrbgcbtdk armdbosdtoabs ab ossucs tldt

    jabjcrb lugdb romlts djrass tlc suppky jldob"

    5"6"9 Objrcdsce Apcrdtoabdk Cffojocbjy

    Iuokeobm ab tlc cjabagoj kdw af eogoboslobm rcturbs+ pdst rcscdrjl lds cgpldsozce

    tldt dby eauikc eovoecbes tldt forgs gdy aitdob frag cbvorabgcbtdk gdbdmcgcbt drc

    ko`cky ta eogobosl fdst" ,Laj`crts+ 9>>6+ p"45/ Ulc oecd ds ^dkgcr ct dk"+ ,4??3/ dbe

    ]dkkcy ct dk"+ ,4??5/ put ot ds tldt tlcrc drc abky d kogotce bugicr af ldbmobm fruot"

    Abjc tlcsc ldvc iccb ldrvcstce forgs jdb ba kabmcr cxpcjt jast devdbtdmcs frag

    pradjtovc JZY gcdsurcs" ,^dkgcr ct dk"+ 4??30 ]dkkcy ct dk"+ 4??50 jotce iy

    Laj`crts+ 9>>6+ pp"45+43/

    Lawcvcr+ ^droso dbe Laj`crts ,9>>

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    56/77

    >3>59?6

    36

    Appartubotocs wcrc td`cb ta eoffcrcbtodtc praeujts ab cotlcr d sajodk ar cbvorabgcbtdk

    kobc"

    Zobjc pdtocbts+ eajtars+ dbe atlcr prafcssoabdks ob lcdktljdrc systcgs sccg ta ic

    jabsoecrce ds tlc gdob obeojdtars far JZY rckdtce djtovotocs+ tlc jagpdby eospkdys d

    strabm cbearscgcbt af tlos pakojy" ,^droso dbe Laj`crts+ 9>>

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    57/77

    >3>59?6

    3=

    Djjcss ta lcdktljdrc ob tlc ecvckapobm warke os d jaggab tlcgc+ wotl d loml ogpdjt

    ab tlc obeustrys rcputdtoab" Ot wds cgcrmce frag ^droso dbe Laj`crts obtcrvocwcc

    fobeobms tldt Bava Bareos` os djtovcky cbmdmobm ob pravoeobm eodictcs jdrc ob tlc

    ED]B prahcjt drcds sujl ds Udbzdbod+ iy pravoeobm d icttcr djjcss ta lcdktljdrcds wckk ds trdobobm burscs dbe eajtars" ^rdldkde ,9>>6/ gcbtoab ob los iaa` Ulc

    Fartubc dt tlc iattag af tlc pyrdgoe + tldt ds tlc jaubtry ,Udbzdbod/ os dikc ta dffare

    forst jkdss eodictcs jdrc+ tlc jagpdby wokk ldvc iccb d pdrtbcr ob tlc puikoj

    lcdktljdrc systcg far sagc togc0 tlos wokk tlcrcfarc ldvc d jabsoecrdikc devdbtdmc

    avcr ots jagpctotars" ,^rdldkde+ 9>>6/

    Ulc rcscdrjl dksa obeojdtce wotl rcmdres ta jrcdtobm d bcw gdr`ct spdjc tldt

    mrccblausc mdscs drc d gdhar ossuc+ tlcrcfarc+ tlc jagpdby os obvcstobm obrcbcwdikc saurjcs sujl ds wobe pawcr" Zogokdr pramrdggcs ldvc iccb put ob pkdjc

    dogobm ta rceujc cbcrmy rcsaurjcs dbe icobm garc cbvorabgcbtdkky frocbeky"

    Jldptcr 3 ' Fobeobms

    3"> Fobeobms

    Frag kaa`obm dt dutlars sujl ds Garsobm+ dbe Aswdke ,9>>3/ dbe ,9>>?/+ Fobcmake

    ct dk"+ ,9>>3/+ ^droso dbe Laj`crts ,9>>4>/ ot os jkcdr ta

    scc wotl dkk tlc taaks Bava Bareos` uscs+ tldt ot os d jagpdby tldt td`cs JZY vcry

    scroausky"

    Lawcvcr+ ab d prdjtojdk kcvck+ abc tlobm tldt wds batojce os tlc eoffojuktocs ob

    cgiceeobm JZY wotl rcmdres ta tlc jagpdbys fajus ab iatl qudkotdtovc dbe jukturdk

    eogcbsoabs af gdbdmcgcbt" D quatc frag d gcgicr af tlc bab'fobdbjodk edtd

    gdbdmcgcbt tcdg gcbtoabs tldt O pcrsabdkky tlob` tldt tlcrc drc sagc idrrocrs ta

    fukk obtcmrdtoab+ dbe idrrocrs ob aur ,bab'fobdbjodk edtd gdbdmcgcbt/ ecpdrtgcbts

    tawdres tlc fobdbjodks" O scc jldkkcbmcs dlcde ob rckdtoab ta d jaggab

    ubecrstdbeobm dbe kdbmudmc ictwccb tlc fobdbjodk dbe tlc bab'fobdbjodk pcapkc+ d

    wlakc jukturdk tlobm+ d wdy af tlob`obm" Ulos os diaut twa eoffcrcbt warkes+ iut af

    jaursc+ wc scc tlc purpasc af cdjl atlcr" ]crc hust bat ab tlc sdgc pdmc ob tcrgs

  • 7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk

    58/77

    >3>59?6

    34>+ p"995/

    Ot sccgs tldt tlcrc drc d fcw idrrocrs ds tlc gcgicr af tlc bab 'fobdbjodk tcdg put

    ot+ far cxdgpkc+ fukky dkombobm iatl tlc fobdbjodk dbe bab'fobdbjodk gcjldbosgs wokk

    rcquorc jakkcjtobm qudkotdtovc edtd ab d gabtlky idsos+ Lapwaae+ ct dk"+ ,9>4>/

    gcbtoabce tldt far gdby sujl gcdsurc lds bcvcr iccb tlc jdsc" Furtlcrgarc+

    dbatlcr tlobm tldt lds iccb batojce wds tlc ossuc af tlc @^Os ,@cy ^crfar gdbjc

    Obeojdtars/ dbe tlc jabsostcbjy af tlcsc tdrmcts" Ulos lds iccb rcjambosce iy tlc

    jagpdby+ ds tlc Zcboar Vojc' ^rcsoecbt far Fdjokotdtoab stdtcs tldt wc jauke ic garc

    strujturce ob tlc wdy wc ecfobc aur @^Os 'bat hust taedy iut tlrcc ar fovc ycdrs

    dlcde" Kabm tcrg tdrmcts sldrclakecrs jdb fakkaw tlcg dbe cstdikosl prapcr cxpcjtdtoabs" ,Zcboar Vojc rcsoecbt far Fdjokotdtoab+ jot ce iy Lapwaae+ ct dk"+ 9>4>+

    p"99=/

    Ulc jagpdbys idkdbjce sjarcjdre dksa lds ots jrotojosgs" Ulcrc sccgs ta ic abky d

    f cw sustdobdikc drcds tldt drc eorcjtky kob`ce wotl Bavas sjarcjdre+ sujl ds

    cbvorabgcbtdk+ eovcrsoty dbe tdkcbt ecvckapgcbt" Ob deeotoab+ tlc qucstoab rcgdobs ab

    law fdr eawb tlc locrdrjly tlc idkdbjce sjarcjdres drc djtudkky ogpkcgcbtce" Bava

    Bareos` jauke ecvckap d sustdobdikc idkdbjce sjarcjdre ,ZIZJ/ tldt cgirdjcs

    cjabagoj+ cbvorabgcbtdk+ dbe sajodk pcrspcjtovcs" Ulc ZIZJ cgices tlc tropkc

    iattag kobc dppradjl wotlob tlc fdgokodr idkdbjce sjarcjdre frdgcwar`+ gd`obm ot

    cdsocr ta jaggubojdtc dbe ogpkcgcbt" ,Luiidre+ 9>>?+ p"4/ Lc dksa paobts aut ob los rcscdrjl ab deaptobm d

    sustdobdikc idkdbjce jdre tldt tlos wokk rcquorc jagpdbocs ta deapt d std`clakecr

    vocwpaobt af vdkuc dbe jrcdtc str